Loma Linda University

TheScholarsRepository@LLU: Digital Archive of Research,
Scholarship & Creative Works
Loma Linda University Electronic Theses, Dissertations & Projects

9-2015

Dietary Intake and Bio-activation of Nitrite and
Nitrate in Newborn Infants
Jesica Ann Jones

Follow this and additional works at: http://scholarsrepository.llu.edu/etd
Part of the Chemical and Pharmacologic Phenomena Commons, and the Medical Pharmacology
Commons
Recommended Citation
Jones, Jesica Ann, "Dietary Intake and Bio-activation of Nitrite and Nitrate in Newborn Infants" (2015). Loma Linda University
Electronic Theses, Dissertations & Projects. 274.
http://scholarsrepository.llu.edu/etd/274

This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative
Works. It has been accepted for inclusion in Loma Linda University Electronic Theses, Dissertations & Projects by an authorized administrator of
TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact
scholarsrepository@llu.edu.

LOMA LINDA UNIVERSITY
School of Medicine
in conjunction with the
Faculty of Graduate Studies

____________________

Dietary Intake and Bio-activation of
Nitrite and Nitrate in Newborn Infants

by

Jesica Ann Jones

____________________

A Dissertation submitted in partial satisfaction of
the requirements for the degree
Doctor of Philosophy in Pharmacology

____________________

September 2015

© 2015
Jesica Ann Jones
All Rights Reserved

Each person whose signature appears below certifies that this dissertation in his opinion
is adequate, in scope and quality, as a dissertation for the degree Doctor of Philosophy.

, Chairperson
Arlin B. Blood, Assistant Professor of Physiology, Associate Professor of Pediatrics

Andrew Hopper, Professor of Pediatrics

Rakesh Patel, Associate Professor of Pathology

Gordon Power, Professor of Physiology

Lubo Zhang, Professor of Pharmacology

iii

ACKNOWLEDGEMENTS

It is with the sincerest gratitude that I begin by thanking my PhD mentor, Dr.
Arlin Blood. Arlin, I will never forget the conversation we had in which you suggested
that I think about pursuing a PhD. Not only because it was one of the many times my
emotions got the best of me, but because your sincere encouragement helped me realize
that I was, in fact, “smart enough” to do this and it changed the trajectory of my career
and life in the most wonderful way. Your unique combination of kindness, generosity,
patience, integrity, easy-goingness, and intelligence has made you the best mentor I could
have hoped for. Your passion for research inspires and motivates me and I will forever be
thankful for everything you have done for me during my time in your lab.
I am also profoundly thankful for the mentorship provided by Dr. Gordon Power.
Gordon, you have been “pulling for me” since the beginning. In challenging me to think
critically about my results, tirelessly reading through and helping me with my writing,
sharing your endless wisdom with me, generously letting me have my wedding reception
in your beautiful home, and in being someone I could always come and talk to, you have
been such a special and important part of my journey and I thank you sincerely.
I would also like to thank the other members of my committee Dr. Andrew
Hopper, Dr. Lubo Zhang, and Dr. Rakesh Patel for their guidance, helpful insights, and
encouragement. Dr. Hopper, I greatly appreciate all the ways you have supported me over
the past seven years: from helping me prepare for intimidating conference presentations
(PAS in Denver!), to enrolling patients in my studies, to offering sage advice on my
career options, to kindly taking Nathan and me out to dinner at WSMRF. Thank you. Dr.
Zhang, thank you for demonstrating how to be a down-to-earth, approachable, and

iv

friendly world-class scientist. Dr. Patel I really appreciate the time you have given by
participating in my committee and all of your helpful suggestions.
To my fellow “Lab B” members: Shannon, Taiming, Kurt, Hobe, Eriko, all of the
neonatology fellows, the summer students and the newest members George and Shawn,
thank you for all of your help; I have thoroughly enjoyed working with you and I cherish
the time I have spent with each of you, both in and out of the lab. In particular, I have to
thank the queen of the lab, the most highly skilled and lowest paid surgeon in the country,
a technical wizard, and engineering guru, Shannon. You have taught me pretty much
every lab technique I know, been a life-saving resource in all of my research, and have
been my dearest friend.
Mom and Dad, thank you for instilling in me a passion for knowledge, for
encouraging me to pursue my dreams and being supportive when those dreams changed,
and for loving me. Jake, thank you for our conversations about life and science and for
understanding me as only my brother can. I would also like to thank Bill and Yholddy,
who have seen me grow and from a teenager in love with their son to a woman in love
with their son and have supported and loved me each step of the way. To my husband
Nathan, thank you for everything, you know. You have made me a better student and
scientist by challenging me to think about and explain my work in unique ways, a better
writer by scouring through every line of my papers with me, and a whole person through
your love and friendship. Lastly, I would like to thank Rhys, who, though he was
unfortunately born too late to participant in any of my experiments, has given me
perspective on what is most important in life.

v

This work has been published in the journals Journal of Parenteral and Enteral
Nutrition, Nitric Oxide, and Pediatric Research and has been funded, in part, by
intramural funding from the John Mace Pediatric Research Grant Fund of the Loma
Linda University School of Medicine, Department of Pediatrics, Loma Linda, CA; the
National Institutes of Health, Bethesda, MD, grant HL095973 (awarded to Arlin B.
Blood); and by the Loma Linda University School of Medicine.

vi

CONTENT

Approval Page .................................................................................................................... iii
Acknowledgements ............................................................................................................ iv
List of Figures .................................................................................................................... xi
List of Tables .......................................................................................................................x
List of Abbreviations ......................................................................................................... xi
Abstract ............................................................................................................................ xiii
Chapter
Introduction ..........................................................................................................................1
1. Introduction ..............................................................................................................1
Dietary Nitrate and Nitrite .................................................................................3
Salivary Nitrate and Nitrite ................................................................................5
Plasma and Urine Nitrite ...................................................................................6
Summary ............................................................................................................8
References ..........................................................................................................9
2. Nitrite and Nitrate Concentrations and Metabolism in Breast Milk, Infant
Formula, and Parenteral Nutrition .........................................................................13
Abstract ............................................................................................................13
Introduction ......................................................................................................14
Methods............................................................................................................16
Breast Milk and Formula Collection and Processing ................................16
Nitrite Metabolism in Breast Milk .............................................................17
Nitrite and Nitrate Assays ..........................................................................20
Data Analysis .............................................................................................20
Results ..............................................................................................................21
Nitrite and Nitrate Concentrations in Breast Milk and Formula................21
Nitrite Metabolism in Breast Milk .............................................................24
Discussion ........................................................................................................33

vii

Nitrite Metabolism in Breast Milk .............................................................35
Neonatal Nitrite and Nitrate Ingestion .......................................................36
Relation to Plasma Nitrite Levels ..............................................................37
Clinical Implications ..................................................................................38
Acknowledgements ..........................................................................................40
References ........................................................................................................41

3. Nitrate Reductase Activity of Bacteria in Saliva of Term and Preterm
Infants ....................................................................................................................45
Abstract ............................................................................................................45
Introduction ......................................................................................................46
Methods............................................................................................................48
Salivary Nitrite and Nitrate Concentrations ...............................................48
Salivary Nitrate Reductase Activity...........................................................49
Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite
and Nitrate Concentrations in Adults.........................................................51
Salivary Bacterial Analyses .......................................................................52
PCR Analysis .............................................................................................53
Real-time PCR Analysis ............................................................................53
Nitrite and Nitrate Assays ..........................................................................55
Data Analysis .............................................................................................55
Results ..............................................................................................................56
Nitrite and Nitrate Concentrations in Saliva ..............................................56
Conversion of Nitrate to Nitrite in Saliva ..................................................57
PCR Detection of Nitrate Reducing Bacteria ............................................61
Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite
and Nitrate Concentrations in Adults.........................................................62
Discussion ........................................................................................................64
Impact of Oral Bacteria on Nitrite Ingestion .............................................64
Linkage between Oral Bacterial Activity and Plasma Nitrite ....................65
Oral Bacteria ..............................................................................................65
Study Limitations .......................................................................................66
Clinical Implications ..................................................................................67
Acknowledgements ..........................................................................................68
References ........................................................................................................69

viii

4. Changes in Plasma and Urinary Nitrite After Birth in Premature Infants at
Risk for Necrotizing Enterocolitis .........................................................................73
Abstract ............................................................................................................73
Introduction ......................................................................................................74
Methods............................................................................................................76
Human Protocol .........................................................................................76
Fetal Sheep Protocol ..................................................................................77
Sample Collection and Handling ...............................................................77
Nitrite and Nitrate Assays ..........................................................................78
Statistical Analysis .....................................................................................78
Results ..............................................................................................................79
Nitrite and Nitrate Concentrations in Infant Plasma ..................................80
Nitrite Concentrations in Newborn Lambs ................................................82
Nitrite Concentrations in Urine ..................................................................82
Plasma Nitrite and Nitrate Concentrations in Preterm Infants with
and without NEC........................................................................................83
Urine Nitrite Concentrations in Preterm Infants with and without
NEC............................................................................................................83
Discussion ........................................................................................................86
Decrease in Plasma Nitrite and Nitrate Concentrations at Birth................86
Nitrite Concentration in Urine ...................................................................88
Possible Role for Nitrite in NEC ...............................................................89
Clinical Perspective ...................................................................................91
Acknowledgements ..........................................................................................91
References ........................................................................................................92
5. Discussion ..............................................................................................................96
Diet ...................................................................................................................98
Dietary Nitrite and Nitrate .........................................................................98
Saliva..............................................................................................................103
Bacterial Conversion of Salivary Nitrate to Nitrite .................................103
Gastrointestinal Tract .....................................................................................107
Intragastric Conversion of Nitrite to NO .................................................107

ix

Intestine ....................................................................................................110
Nitrite Supplementation for the Prevention of NEC in Newborn
Rat Pups ...................................................................................................113
Circulation......................................................................................................115
Circulating Nitrite ....................................................................................115
Summary ........................................................................................................118
Future Directions ...........................................................................................119
References ......................................................................................................127

x

FIGURES

Figures

Page

1. Schema Showing the Pathways and Interconversions of Nitrate, Nitrite,
and Nitric Oxide.......................................................................................................2
2. Comparison of Nitrite and Nitrate Concentrations in Breast Milk ........................22
3. Nitrite Concentrations and Nitrate Concentrations in Formulas Used in
Neonatal Intensive Care Units. ..............................................................................23
4. Summary Nitrite and Nitrate Concentrations in Nutrition Provided to
Newborns in an Intensive Care Setting. .................................................................24
5. Nitrite Metabolism in Breast Milk .........................................................................25
6. Time-Course of Nitrite Disappearance in Samples of Milk Incubated
Under Different Temperatures. ..............................................................................26
7. Initial Rates of Nitrite Metabolism in Samples of Milk Treated with PBS,
NEM, or FeCN .......................................................................................................28
8. Time Course of Nitrite Disappearance in Samples of Milk Treated with
PBD, NEM, or FeCN. ............................................................................................29
9. Time Course of Nitrite in Samples of Milk Treated with Allopurinol. .................30
10. Time Course of Nitrite in Samples of Milk Treated with Inhibitors of
Lactoperoxidase .....................................................................................................31
11. Initial Rates of Nitrite Metabolism in Breast Milk after Treatment with
Enzyme Inhibitors ..................................................................................................32
12. Simplified Schema Showing the Nitrate-Nitrite-NO Axis ....................................34
13. Effect of Antiseptic Mouthwash on the Assay for Oral Nitrate-Reducing
Bacteria ..................................................................................................................50
14. Nitrite Production and Nitrate Reduction by Nitrate-Reducing Bacteria
Cultured from Saliva Samples of Adults ...............................................................51
15. Nitrite and Nitrate Concentrations in Saliva of Infants and Adults .......................57
16. Time Course of Nitrite Production by Nitrate-Reducing Bacteria Cultured
from Saliva Samples ..............................................................................................60
17. Real Time PCR Detection of Nitrate-Reducing Bacteria ......................................62
xi

18. Effect of Antiseptic Mouth Rinse on Adult Blood Nitrite Concentrations ............63
19. Plasma Nitrite and Nitrate and Urine Nitrite Concentrations ................................81
20. Plasma Nitrite Concentrations in Fetal Sheep Before and After Ligation of
the Umbilical Cord and Initiation of Ventilation. ..................................................82
21. Plasma and Urine Nitrite Concentrations in Preterm Infants with or
without Diagnosis of NEC .....................................................................................84
22. Plasma Nitrite and Nitrate Concentrations and Urine Nitrite
Concentrations in Preterm Infants with a Diagnosis of NEC ................................85
23. Schematic Summary Showing Major Differences in the Supply and
Handling of Nitrite and Nitrate by the Adult and Infant. .......................................97
24. Dietary Nitrate and Nitrite Levels for Newborns and Adults ..............................100
25. Nitrate-Reducing Activity in Saliva of Infants and Adults. .................................105
26. Nomogram Showing the Rate of NO Generation in Gastric Fluid for
Various pH and Nitrite Concentrations................................................................110
27. Histological Scores of Ileum Samples Collected from Neonatal Rat Pups .........115
28. Rates of NO Production from Nitrite in Gastric Residual Samples.....................121
29. Mean Nitrite Concentrations Measured in Gastric Residual Samples. ................122
30. Comparison of the Nitrite Concentration in the Plasma, Urine, Diet,
Saliva, Stool, and Gastric Residuals of Infants ....................................................123
31. Nitrate Reduction in Gastric Residual Samples. ..................................................124
32. Nitrite Concentrations in Gastric Fluid Collected from Rats...............................125
33. Nitrite Concentrations in Gastric Fluid and Plasma after IV Nitrite ...................126

xii

TABLES

Tables

Page

1. Demographics of Breast Milk Study Participants ..................................................16
2. Primer Sequences Used for Bacterial PCR Analysis .............................................54
3. Saliva Study Infant Participant Demographics ......................................................56
4. Saliva Nitrate Reductase Study Infant Participant Demographics ........................58
5. Plasma and Urine Study Preterm Patient Demographics .......................................80
6. Summary of the Major Differences in the Supply and Handling of Nitrite
and Nitrate in Adults and Infants ...........................................................................98

xiii

ABBREVIATIONS

NO

Nitric Oxide

NO2-

Nitrite

NO3-

Nitrate

eNOS

Endothelial NO synthase

DASH

Dietary Approaches to Stop Hypertension

NEC

Necrotizing enterocolitis

NICU

Neonatal intensive care unit

PN

Parenteral nutrition

sPN

Starter parenteral nutrition

C

Celsius

cPTIO

2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl3-oxide

NEM

N-ethylmaleimide

FeCN

Ferricyanide

PO2

Partial pressure of oxygen

LPO

Lactoperoxidase

2-MMI

2-mercaptio-1-methylimidazole

3-AT

3-amino-1,2,4-triazole

LLUCH

Loma Linda University Children’s Hospital

MetHb

Methemoglobin

SNO

S-nitrosothiols

PBS

Phosphate buffered saline

PCR

Polymerase chain reaction

BHI

Brain heart infusion

xiv

O2

Oxygen

N2

Nitrogen

H2

Hydrogen

DNA

Deoxyribonucleic acid

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

HCl

Hydrochloric acid

Ct

Cycle threshold

ADMA

Asymmetric dimethylarginine

iNOS

Inducible NOS

EPA

Environmental Protection Agency

WHO

World Health Organization

ADI

Acceptable Daily Intakes

NSAID

Non-steroidal anti-inflammatory drug

ATP

Adenosine triphosphate

GI

Gastrointestinal

L-NAME

NG-nitro-L-arginine methyl ester

FF

Formula-fed

I/R

Ischemia-reperfusion

iNO

inhaled NO

NaCl

Sodium chloride

xv

ABSTRACT OF THE DISSERTATION
Dietary Intake and Bio-activation of Nitrite and Nitrate in Newborn Infants
by
Jesica Ann Jones
Doctor of Philosophy, Graduate Program in Pharmacology
Loma Linda University, September 2015
Dr. Arlin B. Blood, Chairperson

Nitrate and nitrite are commonly thought of as inert end products of nitric oxide
(NO) oxidation, possibly carcinogenic food additives, or well-water contaminants.
However, recent studies have shown that nitrate and nitrite play an important role in
cardiovascular and gastrointestinal homeostasis through conversion back into NO via a
physiological system involving enterosalivary recirculation, bacterial nitrate reductases,
and enzyme-catalyzed or acidic reduction of nitrite to NO. The diet is a key source of
nitrate in adults; however, infants ingest significantly less nitrate due to low
concentrations in breast milk. In the mouth, bacteria convert nitrate to nitrite, which has
gastro-protective effects. However, these nitrate-reducing bacteria are relatively inactive
in infants. Swallowed nitrite is reduced to NO by acid in the stomach, affecting gastric
blood flow, mucus production, and the gastric microbiota. These effects are likely
attenuated in the less acidic neonatal stomach. Systemically, nitrite acts as a reservoir of
NO bioactivity that can protect against ischemic injury, yet plasma nitrite concentrations
fall dramatically at birth and remain markedly lower than in adults for the first few weeks
of life. The physiological importance of the diminished nitrate→nitrite→NO axis in
infants and its implications in the etiology and treatment of newborn diseases such as
necrotizing enterocolitis and hypoxic/ischemic injury are yet to be determined.

xvi

CHAPTER ONE
INTRODUCTION

This dissertation shows that nitric oxide bioavailability is markedly lower in
newborn infants than adults. This is characterized by low dietary nitrate and nitrite
ingestion, a lack of oral bacterial nitrate reductase activity, enhanced urinary nitrite
excretion, and a rapid fall in plasma nitrite levels at birth. Nitric oxide (NO), a potent
vasodilator formed by nitric oxide synthases, is rapidly oxidized to nitrite (NO2-) and
nitrate (NO3-) in the body. Although the biological transformation of NO to nitrite and
nitrate was previously believed to be unidirectional, recent studies have demonstrated
pathways by which nitrate is converted to nitrite and nitrite back into NO via a nitrate →
nitrite → NO axis (1).
The key steps in nitrate and nitrite transport and metabolism are shown in Figure
1 and consist of 1) the introduction of nitrate into the mouth by the diet or active transport
from plasma into the saliva by the salivary glands, 2) reduction of nitrate to nitrite by oral
bacteria, 3) ingestion of nitrite, which is either converted to NO in the stomach or
absorbed into the blood stream, 4) oxidation of nitrite and NO back into nitrate which can
then again be secreted into the saliva, and 5) oxidation of NO into nitrite in the plasma
and tissues (2).
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Figure 1. Simplified schema showing the pathways and interconversions of NO, nitrite,
and nitrate. 1.) Nitrate enters the mouth from the diet and from the plasma by a
concentrating action of the salivary glands. 2.) In the mouth nitrate is converted to nitrite
by commensal bacteria on the tongue (3). 3.) In the acid milieu of the stomach nitrite is
converted to NO by disproportionation (4) or absorbed into the circulation. Nitrite may
also be converted to NO in blood and tissues by the action of metalloproteins (2). NO,
deriving from nitrite or from the conversion of L-arginine to L-citrulline by eNOS, can be
converted to 4.) nitrate by reaction with oxyhemoglobin (5) or 5.) nitrite by
ceruloplasmin (6).

Via this endothelial NO synthase (eNOS)-independent pathway, nitrate and nitrite
are gaining recognition as potential reservoirs of NO bioactivity. This has important
physiological implications considering NO’s wide range of actions throughout the body,
including regulation of vascular homeostasis, neurotransmission, host defense, redox
signaling, and cellular respiration (1). Under hypoxic and ischemic conditions in the
circulation and tissues, nitrite is thought to act as a vasodilator via conversion to NO (7-

2

10). This is of particular importance in the ischemic heart, for example (11). More than
20 studies now show that increasing circulating nitrite levels, even only two-fold higher
than basal levels, protects against ischemic stress in the brain, heart, lungs, liver, and
kidney (see review by Dezfulian, 2007 (12)). Clearly, nitrite shows promise as a therapy
in a multitude of vascular pathologies. Indeed, preclinical trials are currently testing
nitrite as a therapy for pulmonary hypertension (13) and acute myocardial infarction (14).
Furthermore, in the gastrointestinal tract, nitrite-derived NO kills pathogenic bacteria,
protects against gastric ulcers, and increases gastric mucus production and local intestinal
blood flow (15-18). Given these beneficial effects in adults and animals, we asked if
nitrite would also be protective in premature infants who are at significant risk of
suffering from hypoxic/ischemic injury due to dysregulation of cerebral blood flow (e.g.
intraventricular hemorrhage and periventricular leukomalacia) and episodes of inadequate
systemic oxygenation. We reasoned that low plasma nitrite levels in preterm infants
could potentially predispose them to the severe effects of hypoxia and ischemia.
Specifically, we hypothesized that preterm infants would have low plasma nitrite levels
because of diminished activity of each step of the nitrate → nitrite → NO axis. To
address our questions, we looked at the dietary intake of nitrate and nitrite, the bacterial
conversion of salivary nitrate to nitrite, and plasma and urine nitrite levels in preterm and
term newborn infants.

Dietary Nitrate and Nitrite
While about 70% of circulating nitrite comes from eNOS-derived NO oxidation
(19), dietary intake of nitrate and nitrite also contributes to resting nitrite concentrations.
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High levels of nitrate and nitrite are found naturally in green-leafy vegetables like
spinach and beetroot and fruits like strawberries. They are also found in high levels in
processed meat because they are used as curing agents (20). Consumption of dietary
nitrate elevates plasma nitrite, as shown by Lundberg and Govoni who found that adults
who consumed the equivalent of 300 g of spinach 1 saw their plasma nitrite levels increase
from 123 ± 19 nM to 392 ± 68 nM, a striking 4-fold increase, ninety minutes after nitrate
ingestion (21). Two further studies highlight the importance of dietary intake by showing
that plasma nitrite and nitrate concentrations drop by nearly 50% in rats given diets low
in nitrite and nitrate (22-23). Accumulating evidence now indicates that dietary nitrate
ingestion, and subsequent elevation in plasma nitrite, has significant cardiovascular
effects. Increasing dietary nitrate, even at relatively low doses 2(24), has consistently
been shown to decrease blood pressure in healthy normotensive people (24-26) and now
recently in patients with chronic obstructive pulmonary disease (27) and high blood
pressure (28). Furthermore, it protects against ischemia-reperfusion-induced endothelial
dysfunction, decreases platelet aggregation (25), decreases the oxygen cost of exercise,
and improves exercise tolerance (29). It is now proposed that the high nitrate content in
vegetables is one reason why the Mediterranean and Dietary Approaches to Stop
Hypertension (DASH) diets are thought to be so cardioprotective (20). Considering the
important gastro- and cardioprotective effects of nitrate and nitrite ingestion in adults, we
saw the importance of measuring the levels of nitrate and nitrite in the diet of newborn
infants. Given the close link between plasma nitrite and nitrite/nitrate ingestion, we

1

The dose of nitrate used was 10 mg/ml.
Administration of 100 g of beetroot juice produces a significant drop in systolic and diastolic blood
pressures.

2

4

hypothesized that diminished nitrite/nitrate ingestion in premature infants would lead to
low plasma nitrite levels.
The second chapter of this dissertation describes our work of measuring dietary
nitrite and nitrate ingestion in newborn infants. To estimate the amount of nitrate and
nitrite infants ingest daily, we measured nitrite and nitrate concentrations in breast milk,
formula, and parenteral nutrition. In addition, we looked at how clinical practices, such as
freezing and thawing breast milk, effect the concentrations of nitrite and nitrate.

Salivary Nitrate and Nitrite
The third chapter of this dissertation describes our studies of the oral component
of the nitrate → nitrite → NO axis in infants. In adults, the salivary glands concentrate
twenty five percent of circulating nitrate into the saliva, leading to nearly ten-fold higher
concentrations in fasting saliva (~200 µM in saliva versus ~20-40 µM in the plasma)
(21). Twenty percent of this nitrate, together with nitrate from the diet, is reduced to
nitrite by the normal microflora on the tongue. Although nitrate ingestion plays an
important role in determining plasma nitrite levels, it is critically dependent on this
bacterial reduction of salivary nitrate to nitrite. Adults who consume a high nitrate meal
while using antibacterial mouth rinse do not have the corresponding postprandial rise in
plasma nitrite (30). Moreover, if subjects refrain from swallowing saliva after a dietary
nitrate load or are given antibacterial mouthwash to decrease bacterial nitrate-reducing
activity, the hypotensive effects of nitrate are attenuated and there is no inhibition of
platelet aggregation (25, 31). Thus, the many beneficial effects of increasing dietary
nitrate are only seen when there is bacterial activation of nitrate to nitrite.

5

Due to the importance of these bacteria in the nitrate → nitrite → NO axis in
adults, we sought to measure their activity in newborn infants. Conventional wisdom is
that the fetus is sterile 3 and then acquires bacteria during birth and in the following weeks
from the mother’s skin and breast milk and the surrounding environment (33). However,
it was unknown when infants acquire nitrate reducing bacteria and are able to reduce
salivary nitrate effectively. Furthermore, it was unknown if premature infants, who often
receive broad-spectrum antibiotics that would impact bacterial growth (34), have delayed
colonization compared to term infants. Thus, we measured the activity of the specific oral
nitrate-reducing bacteria in both term and preterm infants, in outpatient and intensivecare settings. We also address whether infants are able to concentrate nitrate from the
blood into the saliva and how this impacts their salivary nitrate and nitrite concentrations
and subsequent ingestion. Additionally, we show how a lack of oral nitrate reducing
bacteria influences plasma nitrite levels in adults.

Plasma and Urine Nitrite
Plasma nitrite concentrations of healthy term newborns are measured to be 0.18 ±
0.03 µM (35). These are ~30% lower than the concentrations of adults, which typically
range from 50 to 300 nM (2). Given that elevated nitrite levels protect against ischemic
injury, the reverse is also potentially true: a deficiency in nitrite would enhance risk of
injury. Thus, a significant reduction in plasma nitrite may put newborn infants, and

3

Intriguing new data suggest that the fetus is not, in fact, sterile and receives bacterial colonization from
the placenta (32). Interestingly, the microbiome of the placenta is strikingly similar to that of the mother’s
oral flora and could potentially include these nitrate-reducing bacteria (32), although this remains to be
determined.
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particularly those born prematurely, at an even higher risk for diseases that involve
ischemic injury such as necrotizing enterocolitis (NEC).
As the most common gastrointestinal disease among premature infants, NEC
affects approximately 5-14% of infants born weighing less than 1500 grams (36-38).
Despite over thirty years of clinical management, mortality rates in patients with NEC
remain as high as 20% and the underlying cause remains largely unknown (36, 39).
Premature birth is a prominent risk factor. Consensus is emerging that NEC results from
epithelial mucosal injury secondary to prematurity, feeding substrate, weakened immune
resistance to bacteria, and impaired response to stressors such as ischemia (40, 41).
Considering nitrite’s protective effects in the gastrointestinal tract and in animal models
of ischemia, we hypothesized that preterm infants who are diagnosed with NEC have
lower plasma nitrite levels in the days preceding diagnosis compared to other preterm
infants, term infants, and adults. As discussed in chapter four, we tested this hypothesis
by collecting plasma from preterm infants at risk for NEC for the first three weeks of life.
We also measured the nitrite concentration in urine to determine whether NEC, and any
associated changes in plasma nitrite levels, may impact nitrite excretion in these infants.
In addition to measuring plasma nitrite levels in infants at risk for NEC, we also
attempted to address whether dietary nitrite supplementation would prevent NEC in a
newborn rat pup model of the disease. However, due challenges with this animal model,
we were unable to adequately test our hypothesis. A more thorough explanation of these
experiments and the challenges we encountered appears in the discussion of this
dissertation.

7

Summary
The studies described herein characterize the nitrate → nitrite → NO axis in
newborn infants. Specifically, we measured the levels of nitrate and nitrite in breast milk,
formula, and parenteral nutrition (Chapter 2), the oral bacterial nitrate reducing activity
(Chapter 3), and the plasma and urinary nitrite levels in preterm infants at risk for NEC
(Chapter 4). This work reveals that newborn infants differ greatly from adults due to low
nitrate and nitrite ingestion, negligible bacterial nitrate reduction in the oral cavity, high
urinary nitrite excretion, and diminished plasma nitrite levels. These findings give us a
baseline of nitrate and nitrite bioactivity in newborn infants and help us to begin to
address the possibility of using nitrite supplementation as a therapeutic intervention
against hypoxic and ischemic pathologies common to newborn infants.

8
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CHAPTER TWO
NITRITE AND NITRATE CONCENTRATIONS AND METABOLISM IN
BREAST MILK, INFANT FORMULA, AND PARENTERAL NUTRITION

Abstract
Dietary nitrate and nitrite are sources of gastric NO, which modulates blood flow,
mucus production, and microbial flora. However, the intake and importance of these
anions in infants is largely unknown. Nitrate and nitrite levels were measured in breast
milk of mothers of preterm and term infants, infant formulas, and parenteral nutrition.
Nitrite metabolism in breast milk was measured after freeze-thawing, at different
temperatures, varying oxygen tensions, and after inhibition of potential nitritemetabolizing enzymes. Nitrite concentrations averaged 0.07 ± 0.01 μM in milk of
mothers of preterm infants, less than that of term infants (0.13 ± 0.02 μM) (P < .01).
Nitrate concentrations averaged 13.6 ± 3.7 μM and 12.7 ± 4.9 μM, respectively. Nitrite
and nitrate concentrations in infant formulas varied from undetectable to many-fold more
than breast milk. Concentrations in parenteral nutrition were equivalent to or lower than
those of breast milk. Freeze-thawing decreased nitrite concentration ~64%, falling with a
half-life of 32 minutes at 37 C. The disappearance of nitrite was oxygen-dependent and
prevented by ferricyanide and three inhibitors of lactoperoxidase. Nitrite concentrations
in breast milk decrease with storage and freeze-thawing, a decline likely mediated by
lactoperoxidase. Compared to adults, infants ingest relatively little nitrite and nitrate,
which may be of importance in the modulation of blood flow and the bacterial flora of the
infant GI tract, especially given the protective effects of swallowed nitrite.
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Introduction
Since being established as a potent vasodilator, nitric oxide (NO) has been one of
the most intensely studied compounds in biology and is now considered to be an essential
signaling molecule in a diverse set of pathways. Endogenous NO is produced
predominantly through the conversion of L-arginine to L-citrulline by NO synthase
enzymes. Through reactions with metal-containing proteins and oxygen, endogenous NO
is rapidly oxidized to nitrite (NO2-) and nitrate (NO3-). Although these anions were once
thought to be inert at physiological concentrations, more recent evidence indicates that
nitrite plays a significant role in cardiovascular homeostasis (1) and protects against
hypoxic and ischemic stress in the brain, (2,3) heart, (4,5) lungs, (6) and kidney (7).
Thus, there is growing interest in factors that contribute to the concentrations of nitrite in
the body.
A large portion of plasma nitrite is derived from the oxidation of NO produced by
endothelial NO synthases (8). However, plasma nitrite concentrations are also influenced
by the ingestion of nitrite and nitrate, the latter being converted to nitrite in the mouth by
commensal bacteria present on the dorsal surface of the tongue (9). The oral conversion
of nitrate to nitrite is enhanced by active secretion of nitrate from the blood into the
saliva. Once swallowed, the salivary nitrite can contribute to plasma nitrite
concentrations, (10) or it can be protonated to nitrous acid resulting in a cascade of
reactions leading to several bioactive products including nitrotyrosines, nitrosothiols, and
nitrated lipids (see review by Rocha et al (11)). Although the chemistry of nitrite in the
acidic gastric milieu is not fully characterized, it likely plays a role in the observed effects
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of ingested nitrite in the adult rat. These include increased gastric blood flow (12,13) and
mucus production (13) and protection against ulcers (12,14).
In the newborn period, breast milk and artificial breast milk substitutes (referred
to herein as “infant formulas”) are the sole dietary sources of nitrate and nitrite. As will
be discussed in chapter three, the nitrate-nitrite-NO pathway of adults does not similarly
function in newborn infants due to diminished bacterial conversion of nitrate to nitrite in
the mouth, (15) making the diet a particularly important source of nitrite. Indeed, plasma
nitrite levels are lower in newborn infants in the neonatal intensive care unit (NICU) than
in adults, (16) but the contribution of dietary nitrite and nitrate is not known.
Concentrations of nitrate and nitrite in human breast milk have previously been reported
in milk from mothers of healthy term infants (17,18). However, the effect of preterm
birth and of common manipulations such as freeze-thaw cycles and storage on these
concentrations have not been reported.
In this study we hypothesized that the freeze-thaw and storage of breast milk
results in significant reductions in the dietary intake of nitrate and nitrite of newborns.
We further hypothesized that nitrite and nitrate intake would be significantly reduced in
infants receiving infant formula or intravenous parenteral nutrition (PN) compared to
infants receiving fresh breast milk. We report that the levels of nitrate and nitrite change
in the handling and storage of breast milk and describe potential mechanisms by which
these levels change, including an examination of the roles of various key milk proteins
that may contribute to nitrite metabolism.
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Methods
The experimental protocols were approved by the Institutional Review Board of
Loma Linda University. All chemicals were purchased from Sigma Aldrich (St Louis,
MO) unless otherwise specified.

Breast Milk and Formula Collection and Processing
Fresh breast milk was collected from 11 mothers of term infants and 13 mothers
of preterm infants. The demographics of these mothers and their infants are provided in
Table 1.

Table 1. Demographics of breast milk study participants
Term
(>36 weeks)
11
28.4 ± 2.4
2.0 ± 0.7
4.2 ± 0.6
11
39.4 ± 0.3
3158 ± 323
24.3 ± 8.7

Characteristic
Number of women, n
Maternal age, years
Parity, n
Times breast pumped before donation, n
Number of infants, n
Gestational age, weeks
Birth weight, grams
Infant age at time of collection, days

Preterm
(>35 weeks)
13
28.9 ± 2.0
3.5 ± 0.7
3.8 ± 0.4
13
30.8 ± 0.7
1390 ± 180
18.9 ± 3.9

Feeding, breast pumping, and milk collection routines were not changed by participation
in the study. After milk had been expressed for the first two minutes of pumping, a 3 mL
sample of newly expressed milk was collected in a polyurethane bottle, then divided into
500 µL aliquots and placed on ice. A portion of these aliquots was then immediately
placed in a −20 C freezer, while the remainder was assayed for nitrite and nitrate
concentrations within 30 minutes of collection. To measure the effect of freeze-thawing,
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frozen samples were thawed on ice ~48 hours after collection and then assayed for nitrite
and nitrate.
Nitrite concentrations of colostrum (milk expressed days 1-3), transition milk
(expressed days 4-7), and mature milk (expressed days >7) (18) were measured to follow
changes during the first 3 weeks after giving birth. Samples were collected daily from 12
lactating women and immediately stored at −20 C until assay. Nitrite and nitrate
concentrations were also analyzed in a number of infant formulas used in the NICU of
the Loma Linda University Children’s Hospital (LLUCH). These included: Enfamil®
Premature Lipil (Mead Johnson Nutritionals, Evansville, IN); Enfamil® Lacto Free Lipil,
Enfamil® ProSobee® Lipil, Enfamil® EnfaCare® 22, Enfamil® Premium Infant,
Similac® Special Care (Abbott Nutrition, Columbus, OH); Similac NeoSure®, Similac
Advance EarlyShield®, Pregestimil® Lipil (Mead Johnson Nutritionals); and Nestlé®
Good Start® (Nestlé Infant Nutrition, Florham Park, NJ). Assays were performed in 3
samples from 2 different lots of each formula. The nitrite concentrations were also
measured in 5 samples of starter parental nutrition (sPN) and 14 samples of parenteral
nutrition (PN) used for infants unable to receive milk or formula feeds.

Nitrite Metabolism in Breast Milk
The metabolism of nitrite in breast milk was assessed in a series of experiments in
which nitrite was added to freeze-thawed samples of breast milk to initial concentrations
of ~12 μM. The milk was then incubated at 37 C (unless otherwise stated) and changes in
nitrite concentrations were measured over a 5-hour time course.
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To determine the effect of temperature on the metabolism of nitrite in breast milk,
samples were incubated at 0, 10, 25, and 37 C. In a separate study, aliquots of milk were
boiled for 5 minutes to denature proteins prior to incubation at 37 C. To test whether
nitrite was being oxidized to nitrate, nitrite was added to 6 samples of milk and both
nitrite and nitrate concentrations were measured over a 5-hour time course. In a separate
experiment, additional nitrite was added to breast milk samples for final concentrations
ranging from 10 μM to 160 μM and the increase in nitrate was measured after 5 hours.
The increase in the nitrate concentration in a control sample of milk was subtracted from
the rise in nitrate measured in the nitrite supplemented samples and plotted versus the
initial nitrite concentration.
To assess the role of lipids in the stability of nitrite in breast milk, lipids were
removed from 10 samples of milk by either chemical or centrifugation methods. The
chemical method utilized an adaptation of a method for the delipidation of plasma, (19)
while the centrifugation method involved centrifuging the milk twice at 13,400 rpm for
90 seconds. The lipid content was measured before and after the delipidation procedures
using a Calais Human Milk Analyzer, a midrange infrared spectrophotometer (Metron
Instruments, Inc, Solon, OH).
To measure whether nitrite is reduced to NO in breast milk, nitrite was added to
breast milk and then 100 μL of sample was immediately injected into buffered saline
solution (pH = 7.4) in a purge vessel being continuously sparged with argon in line with a
chemiluminescence NO detector. The presence of NO formation was detected over a
period of 20 minutes (model 280i NO analyzer, Sievers Instruments, Boulder, CO). The
lower limit of NO detection by this method was 20 nM. The possibility of a flux of nitrite
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reduction to NO that could subsequently be oxidized back into nitrite was examined by
incubating milk samples with the NO scavenger 2-4-carboxyphenyl-4,4,5,5tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) (final concentration 200 µM).
Additionally, to address the possibility that nitrite was being reduced to NO and
then combining with thiols to produce s-nitrosothiols, nitrosothiol concentrations were
measured in 6 samples of breast milk over a 3-hour period following the addition of
nitrite using a method described previously (20). The possible role of thiols was also
assessed by measuring the effect of addition of 2 mM N-ethylmaleimide (NEM) (21) on
the rate of nitrite metabolism. To assess whether nitrite metabolism was dependent on
enzymes with oxidizable transition metals, experiments were performed after addition of
10 mM ferricyanide (FeCN).
To determine the role of dissolved oxygen in nitrite metabolism in breast milk, 6
samples of milk were equilibrated with gas phases of various mixtures of nitrogen and
oxygen. The oxygen tension of the samples were adjusted to approximately <5, 7, 37, 73,
or >600 mmHg by measuring the partial pressure of oxygen (PO2) in the sample
(Radiometer, model ABL5, Copenhagen, Denmark). The rate of nitrite metabolism was
determined by measuring the magnitude of decrease in nitrite concentrations after
incubation for 60 minutes at 37 C.
To test the possibility that xanthine oxidase was involved in the metabolism of
nitrite, experiments were conducted following the addition of 100 µM of the selective
antagonist allopurinol. A possible role for the enzyme lactoperoxidase (LPO) was studied
by adding 1 of 3 selective inhibitors of LPO to samples of breast milk. First, to inactivate
the heme center of LPO, 10 µM of 2-mercaptio-1-methylimidazole (2-MMI) was added
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to breast milk. As a second test, 4 mM 3-amino-1,2,4-triazole (3-AT), a compound that
inhibits LPO by covalent binding to the polypeptide chain of LPO rather than the heme,
(22) was added to a separate set of samples. In a third set of samples, the LPO inhibitor
dapson was added to a concentration of 0.6 mmol/L. Optimal concentrations for each
inhibitor were chosen in accordance with those used in the literature (22-25). To assess
whether addition of exogenous LPO would accelerate the loss of nitrite, 10 µL of 1.33
mM LPO from bovine milk was added to 5 mL of breast milk for a final LPO
concentration of 500 nM. Nitrite was added to the sample immediately before 1 mM
hydrogen peroxide was added to initiate the reaction. Control samples lacked hydrogen
peroxide. The samples were incubated at 37 C and the nitrite concentrations were
measured after 10 seconds and 1, 2, 3, 30, and 60 minutes.

Nitrite and Nitrate Assays
Nitrite concentrations were measured by triiodide chemiluminescence as
described by Pelletier et al, (26) enabling quantification above 10 nM with a precision of
±5 nM. Nitrate concentrations were measured by triiodide chemiluminescence after
reduction to nitrite with a nitrate reducing enzyme as previously described (15).

Data Analysis
Data are presented as mean ± standard error. Differences between study groups
were detected using a t-test when the tested hypothesis involved only two sample groups
and a 1-way ANOVA followed by Bonferroni post hoc analysis when three or more
sample groups were involved. One-way ANOVA with repeated measures was used to
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detect significant changes from baseline measurements in time-course experiments. Twoway ANOVA followed by Bonferroni post hoc analysis was used to detect significant
differences between groups in time-course experiments. The overall rate of nitrite
metabolism in breast milk was determined by fitting nitrite disappearance curves to a
monoexponential equation. Where indicated, the initial rate of nitrite metabolism was
determined as the amount of nitrite consumed during the first 60 minutes following
addition of nitrite. Statistical analyses were performed using Prism 5 for Mac OS X
(Graphpad Software, Inc, La Jolla, CA).

Results
Nitrite and Nitrate Concentrations in Breast Milk and Formula
The nitrite concentrations of fresh and freeze-thawed breast milk from mothers of
term and preterm infants are shown in Figure 2A. Nitrite concentrations in the milk of the
mothers of preterm infants were significantly less than in milk from the mothers of term
infants (0.07 ± 0.01 µM vs 0.13 ± 0.02 µM, respectively, P < .01). After freeze-thawing,
nitrite concentrations were significantly decreased in the milk of mothers of both preterm
and term infants (0.03 ± 0.01 µM and 0.04 ± 0.01 µM, respectively, P < .05 compared to
fresh milk).
Nitrate concentrations averaged about 100-fold higher than the nitrite levels in
breast milk, as shown in Figure 2B. Nitrate in the milk of the mothers of preterm infants
(13.6 ± 3.7 µM) did not differ significantly from nitrate concentrations in the milk from
mothers of term infants (12.7 ± 4.9 µM). Nitrate concentrations tended to increase
following freeze-thawing, but this change did not reach statistical significance.
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Figure 2. Comparison of nitrite (A) and nitrate (B) concentrations in breast milk of
mothers of term and preterm infants and after freeze-thawing. C) Nitrite concentrations
are higher in colostrum than transition (**p<0.01) or mature milk (***p<0.001).

To examine changes in nitrite concentrations in milk in the days following birth,
samples were collected from 12 lactating mothers during the first 21 days postpartum
(Figure 2C). In the first 3 days after birth, the nitrite concentration averaged 0.12 ± 0.03
µM. Nitrite concentrations decreased significantly over time following parturition, falling
to 0.05 ± 0.01 µM in days four through seven (1-way ANOVA, P < .01) and 0.01 ± 0.005
µM in days eight through twenty one (P < .001).
In a convenience sample of commercially available infant formulas used
commonly in the Loma Linda University Children’s Hospital (LLUCH) NICU, nitrite
and nitrate concentrations averaged 0.28 ± 0.1 µM and 43 ± 5.8 µM, respectively
(Figures 3A, 3B). The nitrite concentrations were also measured in sPN and PN. Nitrite
concentrations averaged 0.02 ± 0.008 µM in sPN and 0.08 ± 0.03 µM in PN. Nitrate
concentrations averaged 4.6 ± 0.2 µM in sPN and 9.5 ± 0.8 µM in PN. Figures 4A, 4B
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include the nitrite and nitrate concentrations of the PN samples alongside the mean
concentrations in breast milk, colostrum, and formula.

Figure 3. Nitrite concentrations (A) and nitrate (B) concentrations in a variety of
formulas used in neonatal intensive care units. Nitrite levels vary widely, ranging from
barely detectable to more than 13-fold higher than breast milk.
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Figure 4. Summary nitrite (A) and nitrate (B) concentrations in all forms of nutrition
provided to newborns in an intensive care setting. The nitrite and nitrate concentrations in
starter PN and PN samples are similar to those found in breast milk.

Nitrite Metabolism in Breast Milk
The lower concentrations in the freeze-thawed milk compared to fresh samples
indicated a time-dependent metabolism of nitrite. This was confirmed by measuring the
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disappearance of 12 µM nitrite added to freeze-thawed milk and incubated at 37 C. Under
these conditions, nitrite concentrations decreased in a manner approximating first-order
kinetics, with a rate constant of 0.020 ± 0.003 min–1 and an effective half-life of 32
minutes. The initial rates of nitrite metabolism of breast milk incubated at the different
temperatures are shown in Figure 5A. An Arrhenius plot of the nitrite concentrations and
temperature, shown in Figure 5B, revealed an activation energy of 6551 cal•mol–1 and a
Q10 of 1.5.

Figure 5. A) Nitrite metabolism rates under various temperature conditions. B) Arrhenius
plot of nitrite metabolism and temperature. C) Nitrate and nitrite concentrations in six
samples of breast milk incubated over five hours. D) Relationship between initial nitrite
concentration and nitrate production.
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As shown in Figure 6, this rate of disappearance was temperature dependent, with rate
constants of 0.010 ± 0.001 min–1, 0.007 ± 0.001 min–1, and 0.005 ± 0.002 min–1 at 21,
10, and 0 C. When the milk was boiled for 5 minutes to denature proteins, the nitrite
concentrations remained stable when incubated at 37 C (data not shown).

Figure 6. Time-course of nitrite disappearance in samples of milk incubated under
different temperatures, 37 C (▼), 21 C (Δ), 10 C (■), or left on ice (○). Nitrite decreased
in a mono-exponential fashion with apparent half-lives of ~31, ~54, ~75 min, and ~100
min, respectively.

To examine the possibility that nitrite was being oxidized to nitrate, we made
measurements of nitrite and nitrate concentrations following addition of nitrite to an
initial concentration of 12.5 µM in breast milk. We observed an increase in nitrate
concentrations that was comparable in magnitude to the decrease in nitrite concentrations
(Figure 5C), consistent with a pathway of oxidation of nitrite to nitrate. To confirm these
results, additional nitrite was added to a second set of breast milk samples for final
concentrations ranging from 10 to 160 μM. The increase in the nitrate concentration in a
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control sample of milk was subtracted from the rise in nitrate in the nitrite supplemented
samples and plotted vs. the initial nitrite concentration (Figure 5D).
We next examined a number of different possible mechanisms for the
disappearance of nitrite including its reaction with lipids, oxidation/reduction, and
enzymatic catalysis by key milk proteins.
The role of lipids was assessed by measuring nitrite metabolism before and after
delipidation of breast milk samples from mothers of term infants. Fat content in these
samples averaged 2.6 ± 0.1 g/dl and decreased to 1.1 ± 0.2 g/dl after delipification for
samples that were delipified via the chemical process. The extent of delipification was
similar for the centrifugation method, with the starting fat content averaging 3.2 ± 0.4
g/dl and the ending amount averaging 0.8 ± 0.1 g/dl after delipification (P = .31).
However, lipid removal, by either a combination of chemical delipification and
centrifugation or centrifugation only, had no effect on the rate of metabolism of nitrite, as
shown in Figure 7A, and thus the role of lipids could be discounted.
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Figure 7. Initial rates of nitrite metabolism in breast milk after removal of lipids (A),
treatment with the NO scavenger, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1oxyl-3-oxide (B), incubation with N-ethylmaleimide or ferricyanide (C), or at different
partial pressures of oxygen (D).

We were unable to detect any free NO in breast milk following addition of nitrite,
indicating no reduction of nitrite to NO. We also considered the possibility of a rapid flux
of nitrite reduction to NO with subsequent oxidation of the NO back into nitrite. If so, the
removal of NO being produced would be anticipated to speed the metabolic loss of nitrite
by mass action. However, addition of the NO scavenger, cPTIO, did not change the rate
of nitrite metabolism (Figure 7B). Alternatively, any NO produced might have
immediately reacted with cysteine residues to produce nitroso compounds, including snitrosothiols (SNO). However, we did not detect measurable amounts of SNO production
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in any of the milk samples. The combination of these results speaks against a reductive
process that might have converted nitrite to NO.

Figure 8. Time course of nitrite disappearance in samples of milk treated with PBS (○),
N-ethylmaleimide (NEM) [2mM] (▼), or ferricyanide (FeCN) [10mM] (□). The
metabolic loss of nitrite was blocked by incubation with FeCN, suggesting the
involvement of an oxidizable transition metal.

We also investigated the potential roles of catalytic proteins in the metabolism of
nitrite. The prevention of nitrite metabolism after boiling milk is consistent with an
enzyme-mediated metabolism of nitrite. The metabolic loss of nitrite was halted by the
addition of 10 mM ferricyanide, suggesting the involvement of a protein containing an
oxidizable transition metal (Figure 7C and Figure 8). Other experiments tested the
possible binding of nitrite or its metabolic byproducts to thiol groups. Again, the rate of
nitrite disappearance was not affected by the presence of 2 mM NEM used to block
available thiol groups (Figure 7C and Figure 8).
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The role of oxygen in nitrite metabolism was tested by measuring rates of nitrite
disappearance in breast milk samples after equilibration with various concentrations of
oxygen. We found the initial rate of nitrite disappearance to be directly related to oxygen
tensions (Figure 7D). These results are consistent with an oxygen-dependent oxidation of
nitrite to nitrate. In further support of this mechanism, nitrate production was observed to
increase in approximate proportion to the magnitude of nitrite disappearance, as shown in
Figures 5C, 5D.
The blockade of xanthine oxidase, an enzyme previously reported to metabolize
nitrite to NO in breast milk, (27) by addition of allopurinol had no effect on the rate of
nitrite disappearance (Figure 9 and Figure 11A).

Figure 9. Time course of nitrite in samples of milk treated with either PBS (▲) or with
the xanthine oxidase inhibitor allopurinol (100 μM final concentration) (Δ). Xanthine
oxidase appears not to be responsible for the nitrite metabolism measured in breast milk.

Lactoperoxidase, an enzyme previously reported to be present in breast milk, (28)
has been shown to contribute to oxidative mechanisms in milk, (29) in addition to
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catalyzing the oxidation of nitrite in vitro (30). Inhibition of LPO’s iodide-binding site
with 2-mercaptio-1-methylimidazole resulted in the blockade of nitrite metabolism.
Similarly, inhibiting the polypeptide chain of LPO with 3-AT resulted in the complete
inactivation of enzymatic activity, corresponding with a lack of nitrite metabolism
(Figure 10 and 11B). Treating milk samples with excess dapson, a potent inhibitor of
LPO activity, also effectively prevented the loss of nitrite over time. The nitrite
metabolism curves for milk treated with the LPO inhibitors are shown in Figure 10. The
addition of exogenous LPO (final concentration, 500 nM) also accelerated the loss of
nitrite, shortening the half-life from ~30 to ~16 min (Figure 11C).

Figure 10. Time course of nitrite in five samples of milk treated with PBS (▼) or one of
three inhibitors of lactoperoxidase activity: 2-mercaptio-1-methylimidazole (2-MMI) (□),
3-amino-1,2,4-triazole (3-AT) (Δ), or Dapson (○). Inhibition of lactoperoxidase activity
effectively blocked the metabolism of nitrite in breast milk.
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Figure 11. Initial rates of nitrite metabolism in breast milk after treatment with the
xanthine oxidase inhibitor allopurinol (A), inhibition of lactoperoxidase by 2-mercaptio1-methylimidazole, 3-amino-1,2,4-triazole, or Dapson (B), or addition of purified
lactoperoxidase enzyme (C).
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Discussion
These studies sought to determine whether the dietary intake of nitrite and nitrate
is limited for term and preterm infants in the NICU compared to normal infants. We find
that the dietary intake of nitrate and nitrite is significantly lower in infants receiving
freeze-thawed breast milk or breast milk from mothers of preterm infants or in infants
receiving PN. In addition, the intake of nitrate and nitrite of infants receiving infant
formulas range from less than to more than that of infants receiving fresh breast milk,
depending on the brand of formula. Finally, the findings of the current experiments also
add a novel breast milk component to the nitrate-nitrite-NO system, with nitrite being
oxidized to nitrate by LPO, as shown in Figure 12.
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Figure 12. Simplified schema showing the nitrate-nitrite-NO axis.

We find widely variant concentrations of nitrite and nitrate in the diets of
newborn infants in the NICU. The lowest levels of nitrite and nitrate measured were
those in sPN at nearly undetectable concentrations, whereas standard PN had
concentrations comparable to those of breast milk. Infant formulas, however, were found
to have levels ranging from undetectable to nearly 100 times those of breast milk. This
suggests that the manufacturers of commonly used infant formulas do not tightly control
for nitrite and nitrate concentrations, especially as levels were found to vary significantly
across different lots of the same formula.
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With regard to breast milk, our results show that nitrite intake is limited for
preterm infants in the NICU compared to term infants. The milk of the mothers of
preterm infants has significantly less nitrite than the milk of the mothers of term infants, a
finding in line with studies that have shown that the breast milk of mothers of term and
preterm infants differ with respect to a number of components (31-34). Consistent with
reports that the composition of milk changes in the days postpartum, (18, 34) we find that
nitrite concentrations decrease from relatively high levels in colostrum to lower levels in
the days and weeks after birth. The physiological importance of this progression is not
known, but it is worth noting that it is not matched in the care of newborns in the NICU
where initial feeds may be delayed and concentrations in sPN are well below those of
breast milk.

Nitrite Metabolism in Breast Milk
In all samples of breast milk analyzed, nitrite concentrations fell after freezethawing. Our experiments indicate that the mechanism for this fall involves the
metabolism of nitrite by LPO. In support of this idea, we demonstrate that nitrite
metabolism is oxygen-dependent, blocked by the presence of FeCN to oxidize the heme
moiety of LPO, and is blocked by 3 different selective antagonists of LPO activity. We
also demonstrate that the metabolism of nitrite in breast milk is accelerated by the
addition of exogenous LPO. This idea is consistent with previous reports that LPO is
known to contribute to oxidative mechanisms in milk (29) and to metabolize nitrite in
vitro (30).
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In contrast to previous reports that nitrite is reduced to NO by xanthine oxidase in
breast milk,(35) we observed no change in the rate of nitrite metabolism following
addition of allopurinol to block xanthine oxidase activity. Likewise, addition of the NO
scavenger cPTIO also had no effect. Finally, the rate of nitrite metabolism was observed
to be directly proportional to oxygen concentrations, in contrast to the inverse
relationship that would be expected from the reduction of nitrite by xanthine oxidase
(36).
The observation that FeCN prevented nitrite metabolism, together with evidence
of the involvement of oxygen, suggested the involvement of an oxidative process
involving a heme-containing protein. Lactoperoxidase falls into this category and is
known both to contribute to oxidative mechanisms in milk (38) and to metabolize nitrite
in vitro (30). Our finding that each of the three LPO antagonists studied abolished nitrite
disappearance strongly indicates a role for LPO in the metabolism of nitrite in breast
milk. Further supporting the role of LPO in the metabolism of nitrite, we found that
adding purified LPO enhanced the conversion of nitrite to nitrate by approximately 2fold.

Neonatal Nitrite and Nitrate Ingestion
Based on the values reported in this study, we have estimated the daily intake of
nitrate in newborns in the NICU and compared this to adults. Assuming a representative
milk intake of 150 ml•kg–1•day–1 and based on the nitrite and nitrate concentrations
measured in our study, infants consuming fresh breast milk would ingest 0.0007 mg•kg–
1

•day–1 of nitrite and 0.12 mg•kg–1•day–1 of nitrate. This may be compared to adult
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ingestion of nitrite of ~0.109 mg•kg–1•day–1 and ~2.65 mg•kg–1•day–1 of nitrate, based on
an average of seven studies summarized by Pennington (39). Thus, on a per kg body
weight basis, neonatal intake of nitrite and nitrate are only ~0.6% and ~5% of the adult,
respectively. In addition, nitrite intake would decrease another 50%-75% if the milk is
freeze-thawed prior to ingestion and by another 50% if the milk came from the mother of
a preterm infant. For infants who are fed infant formula instead of breast milk, nitrite and
nitrate intake may range from markedly lower to several-fold above that of breast milk–
fed infants, and all formulas provide less nitrite and nitrate than the average adult diet.
The amount of nitrite and nitrate being administered to infants receiving PN is 50%-80%
less than that ingested by term infants receiving fresh breast milk. To date, we are
unaware of any adult studies examining the effects of chronically low intake of nitrate
and nitrite similar to that of infants. Consequently, the physiological effects of this
deficiency in newborns cannot be compared to similar deficiencies in adults.

Relation to Plasma Nitrite Levels
We have recently shown that plasma levels of nitrite in infants in the NICU
average only 35%-55% of the levels of adults (16). One potential explanation is the
current finding that infants ingest far lower amounts of nitrite and nitrate relative to
adults. Demonstrating this effect, two recent studies showed a nearly 50% reduction in
plasma nitrite and nitrate concentrations in rats given diets low in nitrite and nitrate
(40,41). However, it remains to be determined whether reduced plasma nitrite levels in
newborn infants is beneficial or detrimental and thus optimal levels of nitrate and nitrite
in the diet of infants are as yet unknown.
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It is important to consider that until recently, these anions were solely considered
to be toxic by-products of NO metabolism because of their potential ability to form
carcinogenic N-nitrosamines and methemoglobin (MetHb) (42). Cases of
methemoglobinemia have contributed to the idea that nitrate and nitrite ingestion must be
carefully regulated for infants less than three months of age. However, even the high
nitrate and nitrite levels we measured in infant formulas are well below concentrations
known to cause methemoglobinemia, so we can assume that there is a wide range of safe
nitrite and nitrate concentrations in the nutritional sources of newborn infants used today.
Moreover, infants exposed to nitrate intakes as high as 700 mg/day maintained nontoxic
MetHb levels (43) and even when MetHb levels are artificially inflated in newborn cord
blood, there is sufficient MetHb reductase activity such that the half-life of MetHb is only
~3.5 hours (44).

Clinical Implications
The current findings inform speculation on the relationship between ingested
nitrate and nitrite and the occurrence of newborn necrotizing enterocolitis (NEC), a
disease that is characterized by a combination of decreased gastrointestinal blood flow,
breakdown of the mucus barrier lining the lumen of the gut, and invasion by pathogenic
bacteria (45). Nitric oxide, which can be derived from swallowed nitrite, has been shown
to counteract all three of these factors in adult animal models (13,14,46,47). It is clear
that the dietary intake of nitrite and nitrate is significantly lower in infants compared to
adults, whether an infant is receiving fresh breast milk, freeze-thawed breast milk, infant
formula, or PN. We demonstrate in chapter three that the endogenous reduction of nitrate
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to nitrite is markedly diminished in the newborn infants due to a lack of oral nitratereducing bacteria and significantly reduced saliva production (15). As a result, the impact
of adding nitrate to the diet may be limited. Alternatively, addition of nitrite may provide
an important source of NO to support the integrity of the gut lining by promoting enteric
blood flow and mucus production. Although our results do not support the recent
postulate that formula-fed infants are predisposed to NEC because of deficient nitrate or
nitrite intake (48) since the concentrations in most formulas for preterm infants we
measured were well above those of breast milk, given the protective effects of nitrite in
the gastrointestinal tract, it is reasonable to propose that a deficiency of circulating nitrite
could potentially predispose infants to NEC. We explore this hypothesis further in our
work discussed in chapter four.
One possible consequence of low plasma nitrite concentrations would be a
diminished capacity of this anion to function as a reservoir of NO bioactivity, a pathway
thought to be important in protecting tissues against ischemic stress (2-7) (also see recent
review by Weitzberg and Lundberg (50)). Animal studies from multiple laboratories,
species, and disease models now support the idea that increasing plasma nitrite levels, in
some cases by as little as 2- to 3-fold, may protect against hypoxic/ischemic stress (see
review by Dezfulian et al (49)). Interestingly, plasma nitrite concentrations of healthy
term newborns are ~30% lower than those of adults and increase by ~2-fold with no
known adverse effects during administration of inhaled NO (20 ppm) to infants with
pulmonary hypertension (16). However, there are not yet any clinical reports on the
therapeutic effects or safety of exogenous nitrite to treat ischemia/reperfusion injury, and
although it may have therapeutic possibilities, there are also inherent risks to consider.
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For example, in adults, ingestion of nitrate results in a significant decrease in arterial
blood pressure, (10) which would be undesirable in the care of most premature infants. In
addition, MetHb production is of particular concern in neonates as they possess low
levels of MetHb reductase activity, (44) and compared to adults, fetal hemoglobin is
more rapidly oxidized to methemoglobin by reaction with nitrite (50). Thus, the
possibility of methemoglobinemia cannot be ignored.
In summary, infants in neonatal intensive care units ingest markedly lower levels
of nitrate and nitrite than adults on a per kg basis, possibly contributing to lower
circulating concentrations in the plasma. The naturally occurring enzyme lactoperoxidase
is likely a primary factor in the oxidation of nitrite to nitrate during the handling and
storage of breast milk and is likely responsible for the ~65% fall in nitrite concentrations
that occurs through freeze-thawing, potentially exacerbating the effects of the little
dietary nitrite made available to infants. Whether this limited ingestion puts the newborn
infant population at risk for gastrointestinal and cardiovascular diseases or whether
supplementation of these anions in the diet would be beneficial on one hand or safe on
the other calls for future study.
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CHAPTER THREE
NITRATE REDUCTASE ACTIVITY OF BACTERIA IN SALIVA OF TERM
AND PRETERM INFANTS

Abstract
The salivary glands of adults concentrate nitrate from plasma into saliva where it
is converted to nitrite by bacterial nitrate reductases. Nitrite can play a beneficial role in
adult gastrointestinal and cardiovascular physiology. When nitrite is swallowed, some of
it is converted to NO in the stomach and may then exert protective effects in the
gastrointestinal tract and throughout the body. It has yet to be determined either when
newborn infants acquire oral nitrate reducing bacteria or what the effects of antimicrobial
therapy or premature birth may be on the bacterial processing of nitrate to nitrite. We
measured nitrate and nitrite levels in the saliva of adults and both preterm and term
human infants in the early weeks of life. We also measured oral bacterial reductase
activity in the saliva of both infants and adults, and characterized the species of nitrate
reducing bacteria present. Oral bacterial conversion of nitrate to nitrite in infants was
either undetectable or markedly lower than the conversion rates of adults. No measurable
reductase activity was found in infants within the first two weeks of life, despite the
presence of oral nitrate reducing bacteria such as Actinomyces odontolyticus, Veillonella
atypica, and Rothia mucilaginosa. We conclude that relatively little nitrite reaches the
infant gastrointestinal tract due to the lack of oral bacterial nitrate reductase activity.
Given the importance of the nitrate–nitrite–NO axis in adults, the lack of oral nitrate-
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reducing bacteria in infants may be relevant to the vulnerability of newborns to hypoxic
stress and gastrointestinal tract pathologies.

Introduction
Until recently nitrite and nitrate were thought to be biologically inert at
physiological concentrations. However, evidence now indicates that these anions play a
significant role in cardiovascular homeostasis, and in responses to hypoxic and ischemic
stress (See review by Lundberg et al. (1)). Nitrite has been found to provide protective
effects in various animal models of ischemia–reperfusion (2–5). Clinical trials are
currently evaluating the safety and efficacy of nitrite in pulmonary hypertension and
myocardial infarction. While the mechanism underlying the protective effects of nitrite is
not yet well understood, a common hypothesis posits that nitrite is reduced to NO, a
reaction that can either occur spontaneously under acidic conditions such as those found
in the stomach (6), or which may be catalyzed by a number of metal-containing proteins
(7). Irrespective of the mechanism, there is growing consensus that nitrite is
cytoprotective during ischemia–reperfusion insult which has lead to an interest in the
factors that determine plasma nitrite concentrations.
Nitrate, which is inert in mammalian tissues, is converted to nitrite by bacteria
normally found on the dorsal surface of the adult tongue (1, 8). These microbes act upon
nitrate that is concentrated in the saliva by the salivary glands or ingested in the diet.
Dietary nitrate primarily derives from vegetables (9) and from breast milk and formula,
albeit in significantly lower levels, in the diet of newborns (10). These microbes also act
on nitrate that is actively transported from plasma into the saliva by the salivary glands

46

(9). The resulting salivary nitrite is swallowed, and can then be converted to NO by
nonenzymatic disproportionation in the acidic environment of the stomach (11, 12). It can
also enter the circulation where it may serve as a long-term reservoir of NO-bioactivity
(1). Increasing dietary nitrate lowers blood pressure (13, 14), improves exercise
performance (1, 15, 16), and increases plasma nitrite concentrations (14, 17). Disruption
of the salivary nitrate–nitrite–NO pathway in adults by not swallowing saliva prevents the
fall in blood pressure associated with ingestion of nitrate (13). Thus, there is strong
evidence that nitrate-reducing oral bacteria play an important role in determining plasma
nitrite concentrations and the cardiovascular homeostasis of adults.
The bacterial colonization of the mouth and gastrointestinal tract of newborn
infants begins at birth and progresses over the first few weeks of life (18). This
progression is almost certainly altered in an intensive care setting where sanitary
practices and the use of antibiotics may diminish oral bacterial quantity and nitrate
reducing capacity. The appearance of nitrate-reducing bacteria in the mouths of newborn
infants, whether in outpatient or intensive care settings, had not yet been characterized.
Our previous work has shown that plasma nitrite concentrations are lower in
newborn infants in the neonatal intensive care unit compared to adults (19). We postulate
that this is in part due to low oral nitrate reductase activity in newborn infants. The
current studies were designed to measure the activity of nitrate reducing bacteria in
saliva, to characterize the type of oral nitrate reducing bacteria in the mouth of newborn
infants, and to compare newborn and adult salivary nitrite and nitrate concentrations. We
also tested the hypothesis that elimination of oral nitrate-reducing bacteria leads to
decreases in circulating nitrite in adults. Given the importance of the nitrate–nitrite–NO
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axis in adults, the appearance and activity of oral nitrate-reducing bacteria in infants may
contribute to reduced plasma nitrite levels and may be a significant factor in the course of
development.

Methods
All experimental protocols were approved by the Institutional Review Board of
Loma Linda University. Newborn study subjects were recruited from the neonatal
intensive care unit, well-baby nursery, and pediatric outpatient clinic of Loma Linda
University Children’s Hospital. Infants were considered to be term if born after 36 weeks
gestation, and to be preterm if born before 35 weeks gestation; they were excluded from
the study if they were born at 35 or 36 weeks gestation. In addition, infants with
congenital malformations were excluded from the study. The infants’ gestational age,
birth weight, type of feeding, and antibiotic therapy were recorded. Adult subjects were
healthy males and females who, ranged from 24 to 72 years of age, had not used
antiseptic mouthwash within 24 hours, and had not received antibiotic treatment within
two weeks prior to the study. Separate cohorts of adults were studied for the salivary
nitrate and nitrite concentrations and nitrate reductase activity portions of the study.

Salivary Nitrite and Nitrate Concentrations
To determine baseline salivary nitrite and nitrate concentrations, samples were
collected from infants and adults by gently rotating a sterile cotton swab (Kendall Q-Tips,
Tyco Healthcare Group, Mansfield, MA) against the sublingual posterior aspect of the
tongue for 90 seconds. Samples were collected at least one hour following meals. The
cotton end of the swab was removed and immediately transferred to 500 µL of water. The
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weight of the cotton swab was recorded to the nearest milligram before and after
placement in the mouth to determine the amount of saliva collected. The amount of nitrite
and nitrate collected in the swab was determined by comparison with standard curves
generated from known nitrite or nitrate concentrations in 200 µL of water soaked into
swabs and prepared on each day samples were assayed. Both nitrite and nitrate standards
resulted in a linear relationship between the nominal and measured concentrations (nitrite
R2 = 0.98, nitrate R2 = 0.87). Nitrite levels were consistently found to be below the lower
limit of assay detection (10 nM) in samples of dry swabs, demonstrating no background
contamination. There was measurable background contamination of nitrate (60.32 ±
11.61 µM) in the dry swabs, which was subtracted from the raw nitrate levels by the use
of the standard curve.

Salivary Nitrate Reductase Activity
Salivary samples were collected by rotating a sterile cotton swab in a single 360degree twisting motion against the dorsum of the tongue. The volume of saliva collected
was determined via the weight gain of the swab. The swab tip was immediately
transferred to 3.0 ml of sterile anaerobic BHI broth (BD bacto™ brain heart infusion; BD
Bacto™ yeast extract, Becton Dickinson, Franklin Lakes, New Jersey; L-cysteine
hydrochloride monohydrate, Fisher Scientific, Pittsburg PA; Hemin; Menadione; Sigma,
St. Louis MO) and then placed in a water bath held at 37 C. Within ten minutes of
placing the swab in broth, a baseline nitrite measurement was recorded and then 10 mM
nitrate was added (final concentration 333 µM) to provide substrate for the bacterial
conversion to nitrite. Nitrite concentrations were then measured at five-minute intervals
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beginning after the first collection at one minute, and continuing for 30 min. The nitrate
reductase activity was calculated from the slope of a linear regression fit to the plot of
increasing nitrite concentrations over time, with the result providing nanomoles of nitrite
production per minute per milligram of saliva collected. We verified this method of
measuring oral nitrate reductase activity by treating four adult subjects with six antiseptic
mouth rinse treatments consisting of 0.12% chlorhexidine solution (Peridex, 3 M ESPE
Dental, St. Paul, MN) over a period of three days (12-hour intervals). Baseline activities
were recorded before the mouth rinse treatment, and immediately following the last
mouth rinse treatment, demonstrating that the subjects no longer had any measurable
activity (Figure 13). Subsequent measurements at 8, 24, and 48 h after the last treatment
indicated a return to baseline levels of nitrate reductase activity within 48 h.

Figure 13. Effect of antiseptic mouthwash on the assay for oral nitrate-reducing bacteria.
Following six treatments with antimicrobial mouth rinse at twelve hour intervals, oral
nitrate reductase activity in four adult subjects was decreased to unmeasurable levels
compared to baseline values. Nitrate reductase activity returned to normal within 48 h
following the last antimicrobial mouth rinse treatment.
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To verify that nitrate was being metabolized in the broth as nitrite concentrations
were increasing, we also measured the rate of nitrate disappearance using swab samples
from five adult subjects. Over the course of the 30-min experiment, the mean rate of
nitrate disappearance was 103 ± 20 nmol•min-1•mg-1 of saliva, while the mean rate of
nitrite production was 47 ± 17 nmol•min-1•mg-1 (Figure 14).

A

B

Figure 14. A) Time course of nitrite production and nitrate reduction by nitrate-reducing
bacteria cultured from saliva samples of five adults. B) Summary of kinetic results based
on average rates of change of nitrite and nitrate concentrations with time.

Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite and Nitrate
Concentrations in Adults
Twenty-four normal healthy adults received six mouth rinse treatments over a
period of three days (at 12-h intervals) with either 0.12% chlorhexidine solution (n = 12)
or saline solution (n = 12) as placebo control. Saliva and venous blood samples were
collected just prior to the first mouth rinse, and then again one to two hours following the
final mouth rinse. Blood was immediately added to a nitrite preservation solution (4:1
v/v) (20), deproteinized by methanol precipitation (1:1 v/v), and stored at 70 C until
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assay. Approximately 5 ml of saliva was collected by expectoration of passively secreted
saliva into a 50 ml tube, which was immediately frozen until assay at a later date.
Subjects were asked to refrain from eating high-nitrate foods (e.g. beets, radishes,
hotdogs, and leafy greens) from 24 h prior to the first sample until after the collection of
the final sample.

Salivary Bacterial Analyses
To assess for the presence of bacteria capable of nitrate reductase activity, PCR
analysis and real-time PCR was performed on bacterial DNA isolated from saliva
collected from healthy infants in the pediatric outpatient clinic, and from preterm infants
in the NICU and from healthy adults after six chlorhexidine treatments. We chose to test
for the presence of the four most prevalent nitrate reducing bacterial species in the adult
mouth (21): Veillonella atypica, Actinomyces odontolyticus, Rothia mucilaginosa, and
Staphylococcus epidermidis. Saliva was collected using a Vacutainer™ anaerobic
specimen collection vial (Becton–Dickinson, Sparks, Maryland) by rotating a sterile
anaerobic specimen collector swab in one 360-degree rotation against the dorsum of the
tongue. Swabs were stored in an anaerobic specimen collector for up to 48 h at room
temperature after which they were placed in 5.0 ml of sterile anaerobic brain heart
infusion (BHI) broth. The swabs were then incubated overnight at 37 C in an anaerobic
chamber (0% O2, 99.8% N2, 0.2% H2), until the broth had reached an optical density of
0.8–1.0 (600 nm). Bacterial DNA was extracted using a Wizard Genomic DNA
purification kit (Promega Corporation, Madison, WI) following the manufacture’s
protocol for isolating genomic DNA from gram positive bacteria. For efficient lysis, 60
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µL of 10 mg/ml lysozyme and 60 µL of 10 mg/ml lysostaphin (Sigma–Aldrich, St. Louis,
MO) were added to each sample. The DNA was resuspended in 100 µL of rehydration
solution, quantified using a NanoDrop 2000 (Thermo Scientific, Wilmington, DE) and
then stored at 70 C.

PCR Analysis
Qualitative PCR was performed on the DNA samples initially to confirm the
accuracy of the primers used for the four bacterial species of interest, and to confirm the
presence of target bacterial genes in the DNA samples. The primers for PCR analysis are
listed in Table 1 and were designed using the NCBI primer select program. The reaction
mixture (50 µL) contained 1 µg of template DNA in the high fidelity PCR master mix
(Invitrogen, Carlsbad, CA). PCR cycling conditions were 1 cycle of 5 min at 94 C
followed by 30 cycles of 30 s at 94 C, 30 s at 54 C and 1 min at 68 C with final extension
of 5 min at 68 C.

Real-time PCR analysis
Real time PCR was carried out on 1 µg aliquots of purified DNA using a Smart
cycler II (Cepheid, Sunnyvale CA). The primers for the real time analysis are listed in
Table 2. The amplification efficiency of each primer set was determined empirically by
using DNA template dilutions over four orders of magnitude. The amplification
efficiency for each primer set varied between 95.1% and 102.5%, showing that the
amplicons were generated with comparable efficiency. The specificity of the
amplification was ascertained based on the melting peak generated during each run.
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Table 2. Primer sequences used for bacterial PCR analysis.
Bacterial species
1. Veillonella atypica

2. Rothia mucilaginosa

3. Actinomyces
odontolyticus

4. Staphylococcus
epidermidis

Target gene primer set
Forward primer- 5’ –
GTGCTGCAGAGAGTTTGATCCTGGCTCAG -3’
Reverse primer-5’CACGGATCCTACGGGTACCTTGTTACGACTT -3’
Forward primer-5’-AGCCTCAGGG
ATTGATGGGTTCTT-3’
Reverse primer- 5’-TTCTGGTGGTT
GTACAGGGCGTTA-3’
Forward primer- 5’- GCGGATTAATT
CGATGCAACGCGA-3’
Reverse primer- 5’ CATTGTAGCAT
GCGTGAAGCCCAA-3’
Forward primer- 5’-CTGCCTTTCAA
TGCGAGTTGGCTT-3’
Reverse primer-5’-ACAGCTAAACT
TGCAGCATGTGGG-3’

The real time-PCR reaction contained 12.5 µL of QuantiTect SYBR Green qPCR master
mix (Qiagen, Valencia, CA), 0.2 µM of each gene-specific primer and 1 µL of DNA
template. The cycling conditions were 50 C for 2 min, 95 C for 2 min, then 40 cycles of
94 C for 15 s, 58 C for 30 s, and 72 C for 30 s. Distilled water was used as a negative
control in each run. All reactions were carried out in triplicate. A standard curve was
generated using dilution of the DNA from each species of bacteria plotted against the
cycle threshold value (Ct). The concentration of DNA was converted to copy number
using the formula n = NA – m/MW – L where n = the number of target sequence copies
per microliter, NA = Avagadro’s constant (mol-1), m = mass of the amplicon per
microliter, MW = mean molecular weight of 1 base pair, and L = amplicon length in base
pairs. The Ct values obtained were plotted against DNA concentration to generate
standard curves from which the cutoff Ct for each bacterial species was determined. The
cutoff Ct value, above which the absence of the bacteria is indicated, was 43 for
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Veillonella atypica, 49 for Rothia mucilaginosa, 39 for Actinomyces odontolyticus, and
47 for Staphylococcus epidermidis.

Nitrite and Nitrate Assays
Nitrite concentrations were measured by triiodide chemiluminescence as
described by Pelletier et al. (20), enabling quantification above 10 nM with a precision of
±5 nM. Nitrate concentrations were measured by incubation of 205 µL of sample with 5
µL nitrate reductase enzyme (10 U/ml solvent, Roche, Indianapolis IN) in 10 µL of 1 M
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer solution (Fisher
Scientific, Pittsburgh PA), 10 µL of 0.1 mM flavin adenine dinucleotide disodium salt
hydrate (Sigma Aldrich, St. Louis, MO), and 20 µL of 1 mM nicotinamide adenine
dinucleotide phosphate-oxidase tetrasodium salt (Roche, Indianapolis, IN) at 37 C for 45
min to convert all the nitrate to nitrite, which was then measured by triiodide
chemiluminescence. Whole blood nitrate concentrations were measured by
chemiluminescence assay following reduction of nitrate to NO in a purge vessel
containing vanadium III and HCl at 90 C.

Data Analysis
Data are presented as means ± standard error. Differences between study groups
were detected using Student’s t-test for two group comparisons and one-way ANOVA
followed by Bonferroni post hoc analysis for comparison of three or more datasets.
Oneway ANOVA with repeated measures was also used to detect significant changes
from baseline measurements in time-course experiments. Two-way ANOVA followed by
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Bonferroni post hoc analysis was used to detect significant differences between groups in
time-course experiments. Statistical analysis was performed using Prism 5 for Mac OS X
(Graphpad Software, Inc, La Jolla, CA).

Results
Nitrite and Nitrate Concentrations in Saliva
Nitrite and nitrate concentrations were measured in saliva collected from ten
infants and twelve healthy adults. The results are shown in Figure 15 and participant
demographics are provided in Table 3.

Table 3. Saliva study infant participant demographics.
Infants
10
39 ± 0.3
3662 ± 170
3.1 ± 0.3
0
7
3

Participants, n
Gestational age, weeks
Birth weight, grams
Age at time of collection, days
Infants receiving antibiotics, n
Breast fed, n
Formula and breast milk fed, n

Nitrite concentrations in infant saliva averaged 8.2 ± 5.6 µM. These concentrations were
significantly lower than adult salivary nitrite concentrations which averaged 50 ± 13 µM
(p = 0.0501) (Figure 15A). Nitrate concentrations were measured in saliva collected from
ten infants and fourteen adults and averaged 284 ± 83 µM in the saliva of infants and
were not measurably different than those found in adults (681 ± 184, p = 0.11) (Figure
15B). The newborn salivary nitrate concentrations were approximately ten-fold greater

56

than previously reported newborn plasma nitrate levels (19,22,23), demonstrating that
salivary glands are able to concentrate nitrate from the plasma into the saliva of infants,
and to levels comparable to adults. Notably, the amount of saliva obtained during the
timed 90-second collection periods from infants (39 ± 8 µL) was less than the amount
collected from adults (143 ± 15 µL) (p < 0.001).

A

B

Figure 15. Nitrite and nitrate concentrations in saliva of infants and adults. (A) Nitrite
concentrations in the saliva of infants (8 ± 5 µM) were less than adult saliva (55 ± 22 µM,
*= p < 0.01). (B) Salivary nitrate levels were not significantly lower in the saliva of
infants (328 ± 97 µM) than in the saliva of adults (538 ± 125 µM).

Conversion of Nitrate to Nitrite in Saliva
Oral bacterial nitrate-reducing activity was measured in fresh oral swabs
immediately after placing them in culture media. Swabs were obtained from 25 infants
less than five days of age, from 19 infants between 14 and 40 days of age, from 9 infants
approximately two months old, and from 13 healthy adults. The demographics of the
infant subjects are shown in Table 4.
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Table 4. Saliva nitrate reductase study infant participant demographics.

Participants, n
Gestational age,
weeks
Birth weight, grams
Age at time of
collection, days
Breast fed, n
Nipple/gavage breast
milk fed, n
Formula fed only, n
Intravenous feeding,
n

NICU
preterm
on
antibiotics
7
32.1 ± 0.7

NICU
term on
antibiotics

NICU
preterm

Outpatient
term

NICU
term >2
weeks old

Outpatient
> 2 weeks
old

Outpatient
2 months

3
2

5
38.4 ±
0.5
3350 ±
235
26.6 ±
5.6
1
1

NICU
preterm >
2 weeks
old
8
30.8 ±
1.1
1581 ±
174
27.3 ±
2.9
0
7

1495 ±
201
3 ± 0.4

6
38.6 ±
0.5
3322 ±
86
4.2 ± 0.3

5
32.6 ±
0.7
1964 ±
124
4.6 ± 0.2

7
39.2 ±
0.5
3391 ±
140
3.7 ± 0.4

6
38.9 ±
0.7
3199 ±
133
17.2 ±
1.7
6
0

9
39.5 ±
0.3
3425 ±
127
64.6 ±
1.1
7
0

0
3

2
3

0
2

0
4

0
1

2
1

2
0

3
0

1
0

0
0

2
0

Swabs collected from infants contained similar amounts of saliva as those collected from
adults (17 ± 1 vs. 17 ± 3 mg, respectively, p = 0.9). The rate of nitrite production in the
cultures, normalized to the weight of the saliva collected, was linear during the 30 min
sampling period, as shown in Figure 16A, with the slope thus providing an index of
bacterial nitrate reductase activity. In samples taken from adults nitrite was produced at a
rate of 147 ± 36 nmoles•min-1•mg-1. In marked contrast, however, saliva cultures from
newborns showed little or no detectable nitrite production.
In the cultures collected from preterm (n = 6) and term (n = 6) infants on
antibiotics, the rates of nitrite production were not significantly different than zero (0.05
± 0.04 nmoles•min-1•mg-1 saliva and 0.04 ± 0.11 nmoles•min-1•mg-1 saliva,
respectively). In addition, there was no appreciable nitrite production in the salivary
cultures taken from preterm infants in the NICU not receiving antibiotics, or from healthy
term infants less than two weeks of age in the well-baby nursery and outpatient clinic (4
± 4 nmoles•min-1•mg-1 saliva and 5 ± 3 nmoles•min-1•mg-1 saliva, respectively). Nitrite
production was detectable in saliva samples collected from healthy infants between 14
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and 40 days of age in the outpatient clinic (22 ± 15 nmoles•min-1•mg-1) as well as term
(23 ± 12 nmoles•min-1•mg-1) and preterm infants in the NICU (28 ± 19 nmoles•min1

•mg-1), although this activity was still measurably less than that of the adults (p < 0.01).

Even by two months of age, the rate of nitrite production (23 ± 12 nmoles•min-1•mg-1)
was significantly lower than that of adults (p < 0.01, Figure 16B).
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Figure 16. A) Time course of nitrite production by nitrate-reducing bacteria cultured
from saliva samples. After introduction of nitrate substrate into cultures, nitrite was
measured in samples from adults (♦), infants greater than two weeks of age (◊), newborn
infants less than five days old (○), and newborn infants less than five days old receiving
antibiotics (▲). B) Summary of kinetic results based on average rates of change of
nitrite concentration with time, as shown in A. There was no significant nitrite production
in the saliva of infants <5 days old, regardless of whether they were on antibiotics (abx).
There was significant nitrite production in the infants older than two weeks (+ = p<0.01),
and nitrite production was significantly greater in the adult saliva compared to infants
(*** = p<0.001).
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PCR Detection of Nitrate Reducing Bacteria
To investigate the possibility that the lack of nitrate reducing activity in the
samples collected from infants was due to the absence of nitrate-reducing bacteria, PCR
detection was performed on samples collected from five healthy term infants in the
outpatient clinic and seven preterm infants in the NICU, who were all less than five days
of age. The specificity of the amplification of target genes was confirmed by
conventional PCR analysis (data not shown). The quantitative PCR demonstrated the
presence of Veillonella atypica and Rothia mucilaginosa in all the infants studied.
Actinomyces odontolyticus was present in four of the five term infants and five of the
seven preterm infants, and Staphylococcus epidermidis was present in two of the five
term infants and all of the preterm infants studied (Figure 17). These values suggest that
the most abundant oral nitrate reducing bacteria in adults are also present in the mouths
of neonates within a few days after birth. Thus, the lack of nitrate reductase activity in
infants is more likely to be due to low abundance or activity of these bacteria as opposed
to lack of inoculation. To assess this possibility further, PCR was also performed on eight
adult subjects after six treatments with chlorhexidine, which lowers oral nitrate reductase
activity by our assay to levels comparable to those of infants (see above). We found
detectable presence of all four bacterial species in all adults studied, with the exception of
one adult in whom Actinomyces odontolyticus was not detectable, suggesting that
although chlorhexidine significantly decreases overall oral nitrate reducing activity, it
does not completely eliminate the presence of nitrate reducing bacteria.
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Figure 17. Real time PCR detection of nitrate-reducing bacteria. The presence of
Veillonella atypica, Rothia mucilaginosa, Actinomyces odontolyticus, and Staphylococcus
epidermidis in bacterial cultures collected from the mouths of term (●) and preterm (○)
infants and adults () was confirmed using primers specific to the respective bacteria.
Horizontal gray bars represent the cutoff Ct value, below which the presence of the
bacteria is confirmed. The data indicate the presence of most of these nitrate reducing
bacteria in the infant mouth within the first few days of life.

Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite and Nitrate
Concentrations in Adults
Changes in blood nitrite were examined in 24 adult subjects after three days of
treatment with either anti-microbial mouth rinse or placebo. Mean blood nitrite
concentration decreased by approximately 20% from 0.27 ± 0.01 µM to 0.22 ± 0.01 µM
following chlorhexidine treatment (p < 0.05), but was not affected by the placebo. As
shown in Figure 18, blood nitrite concentrations decreased in 9 out of 12 subjects
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following chlorhexidine mouth rinse treatments, compared to only 5 out of 12 subjects
with placebo mouth rinses. There were no significant differences in the blood nitrate
concentrations of the study subjects before or after treatment with chlorhexidine (41 ± 8
vs. 48 ± 7 µM) or placebo (35 ± 4 vs. 32 ± 6 µM, data not shown). Saliva nitrite
concentrations fell from 322 ± 70 to 109 ± 35 µM (p < 0.01) following three days of
antimicrobial mouthwash, and were unchanged (246 ± 54 vs. 284 ± 45 µM) following
treatment with placebo. Saliva nitrate concentrations increased from 189 ± 39 to 1083 ±
268 µM (p < 0.01) following the antimicrobial mouthwash, and were again unchanged
(118 ± 40 vs. 141 ± 37 µM) following treatment with placebo.

B

Figure 18. Effect of antiseptic mouth rinse on adult blood nitrite concentrations. Blood
nitrite concentrations in healthy adult volunteers were significantly decreased by ~19%
compared to baseline levels following six treatments with antiseptic mouth rinse
(chlorhexidine) at 12-hour intervals (*=p<0.04). No significant change was observed in a
parallel group of placebo (saline) control subjects.
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Discussion
The current studies demonstrate that bacterial nitrate reductase activity in the
mouth of neonates is minimal compared to that of adults. The low nitrate-reducing
activity in the newborn persists for at least the first two months of life, and results in
significantly lower salivary nitrite concentrations. In spite of this reduced activity, PCR
evidence shows that newborn mouths do contain the major nitrate-reducing bacteria
found in adults. This suggests that the diminished nitrate-reducing activity of newborns
may be due to lower numbers of these bacteria, as opposed to a lack of inoculation. Thus,
this study shows that oral nitrite production, which plays a prominent role in
cardiovascular and gastrointestinal homeostasis of adults, has less capacity to function in
neonates during the first few weeks of life.

Impact of Oral Bacteria on Nitrite Ingestion
Normally, adults swallow on average 600 ml of saliva per day (24). To our
knowledge, the quantification of saliva production or ingestion in newborns has not yet
been accomplished due to obvious technical challenges. However, the newborn mouth is
relatively dry compared to the adult mouth, as is reflected by significantly lower volumes
of saliva collected by the oral swabs in the current study. In adults, even when nitratereducing bacteria are present, not swallowing saliva effectively blocks the physiological
effects of dietary nitrate (13). Thus, it is reasonable to hypothesize that the relatively low
rate of saliva production in newborns, coupled with a low concentrations of nitrite in the
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saliva and diet, has a compounded impact upon overall nitrite ingestion by newborn
infants resulting in significantly decreased nitrite intake compared to adults.
Linkage between Oral Bacterial Activity and Plasma Nitrite
We have recently observed that the blood nitrite concentration of newborn infants
(1.4 ± 0.5 days of age) is approximately 35–55% lower than that of adults (19). The
current studies found that a blockade of oral bacterial nitrate reduction activity in adults
resulted in a 20% reduction in blood nitrite concentrations, demonstrating that oral nitrate
reductase activity makes a significant contribution to basal plasma nitrite concentrations.
This finding is consistent with experiments in which increases in plasma nitrite,
following nitrate ingestion, have been shown to require the activity of oral bacteria (13,
25). Notably, plasma nitrite concentrations are also heavily influenced by NO derived
from endothelial nitric oxide synthase (eNOS) activity (26, 27). However, the rate of
eNOS activity in newborns, relative to adults, has not been determined.

Oral Bacteria
A number of specific nitrate-reducing bacteria, most of them facultative
anaerobes, have been identified in the oral cavity of adult humans (21, 28). Previous
studies have reported the presence of Veillonella and Actinomyces spp. (29, 30) in infants.
To our knowledge, however, our work is the first to report both the presence of nitrate
reducing bacteria and measurement of oral nitrate reducing activity. The significantly
lower nitrate reductase activity in newborns, despite evidence of their mouths having
been colonized by these bacteria, may be due to relatively low bacterial abundance at this
age, a factor not measured in the current study. This idea is supported by our observation
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of the presence of these bacteria in the mouths of adults following chlorhexidine
treatment, concomitant with a lack of measurable nitrate reductase activity. The
significantly lower bacterial nitrate reductase activity observed in infants in both an
intensive care setting and the home environment, regardless of whether the infants were
receiving antibiotics, serves as further evidence that the low nitrate reducing activity of
newborns was not due to a delayed inoculation of these infants with nitrate-reducing
bacteria.

Study Limitations
We observed that salivary nitrite concentrations in adult saliva collected with
cotton swabs (55 ± 22 µM) were consistently lower than concentrations measured in
saliva collected by expectoration (284 ± 63 µM) in addition to being lower than most
previously reported salivary nitrite concentrations which range from 90 to >670 µM.
Standard curves generated by dipping swabs in small amounts of water with varying
concentrations of nitrite were highly linear with significant slope. However, we observed
that nitrite concentrations measured in ten expectorated adult saliva samples were
significantly higher than concentrations measured from samples collected at the same
time using swabs (131 ± 32 vs. 45 ± 14 µM, p = 0.024). This suggests that nitrite in saliva
may bind to the swab itself or to other components of saliva that bind to the swab,
resulting in an artifact of low absolute nitrite concentrations. Nevertheless, the
measurement of nitrite in saliva collected in the swabs provides a relative comparison of
newborn and adult concentrations where collection of expectorated samples from infants
is not possible. Improved methods of neonatal saliva collection in the future may lead to
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more precise determinations of absolute concentrations in neonatal saliva. It is also
important to note that although our findings indicate that nitrate reducing activity is
markedly less in the mouths of infants compared to adults despite the PCR detection of
nitrate reducing bacteria, the PCR results cannot be used as a quantifiable comparison of
bacterial abundance in infant and adult mouths due to the method of sample collection
and overnight culture prior to DNA isolation.

Clinical Perspective
Hypoxia and ischemia play key roles in several diseases of the newborn period.
Because nitrite is protective against hypoxic and ischemic insults, questions arise as to
the potential role of nitrite supplementation of the newborn infant. Such treatment may be
particularly beneficial to premature infants who require prolonged periods of intubation
and mechanical ventilation which has been demonstrated in adults to result in significant
depletion of intragastric NO, presumably due to marked decreases in saliva production
and swallowing (31). Necrotizing enterocolitis, the most common gastrointestinal
disorder to affect premature infants, likely results from a combination of decreased
gastrointestinal blood flow, breakdown of the mucus barrier lining the lumen of the gut,
and invasion by pathogenic bacteria (32). Intragastric nitric oxide derived from nonenzymatic disproportionation of swallowed salivary nitrite counteracts all three of these
factors in adult animal models (31, 33, 34). However, the gastric pH of newborn infants
is relatively high compared to adults (35, 36), leading to diminished NO production,
which may hinder its gastroprotective effects and compound the effects of low levels of
nitrite ingestion in newborn infants.
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Premature infants are also at significant risk of suffering intraventricular
hemorrhage and episodes of inadequate systemic oxygenation. Circulating nitrite
provides protection against cerebral vasospasm following subarachnoid hemorrhage in
baboons (37), and can also increase cerebral blood flow (38) and decrease oxygen
consumption during hypoxic stress (39). During reperfusion, nitrite is found to protect
against oxidative stress and to reduce the generation of harmful reactive oxygen species
(40). Whether these protective effects of nitrite are diminished in neonates due to the
attenuation of enterosalivary nitrate–nitrite–NO metabolism calls for future study.
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CHAPTER FOUR
CHANGES IN PLASMA AND URINARY NITRITE AFTER BIRTH IN
PREMATURE INFANTS AT RISK FOR NECROTIZING ENTEROCOLITIS

Abstract
Plasma nitrite serves as a reservoir of NO bioactivity. Because nitrite ingestion is
markedly lower in newborns than adults, we hypothesized plasma nitrite levels would be
lower in newborns than in adults, and that infants diagnosed with NEC, a disease
characterized by ischemia and bacterial invasion of intestinal walls, would have lower
levels of circulating nitrite in the days prior to diagnosis. Single blood and urine samples
were collected from nine term infants and twelve adults, 72 preterm infants every five
days for three weeks, and from 13 lambs before and after cord occlusion. Nitrite fell 50%
relative to cord levels in the first day after birth; and within 15 min after cord occlusion in
lambs. Urinary nitrite was higher in infants than adults. Plasma and urinary nitrite levels
in infants who developed NEC were similar to those of preterm control infants on Days 1
and 5, but significantly elevated at 15 and 20 days after birth. Plasma nitrite falls
dramatically at birth while newborn urinary nitrite levels are significantly greater than
adults. Abnormally low plasma nitrite levels do not appear to predispose infants to NEC.
Yet, active NEC is associated with elevated plasma and urinary nitrite levels.
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Introduction
The free radical molecule nitric oxide (NO) plays a key signaling role in a number
of physiological processes. NO is produced from L-arginine by the action of NO synthase
enzymes found throughout the body. NO can diffuse readily through tissues to distances
several cells away from its site of production. However, its half-life in whole blood is
<10 ms and thus the range of free NO itself is paracrine in nature (1). As a free radical,
NO can be metabolized by a number of different biochemical pathways. Many of these
pathways result in nitrogen oxide species that are stable enough to circulate systemically
yet retain the bioactivity of NO, such as nitrite and nitrosothiols. Other pathways oxidize
free NO to nitrate. While nitrate is inert in mammalian cells, it can be secreted in saliva
and converted to nitrite by oral bacteria (2), although this pathway is markedly
diminished in the newborn compared to the adult (3). These products of NO metabolism
make up a humoral source of NO bioactivity (see review by Lundberg and Weitzberg
(4)). Thus, it is now recognized that the overall level of NO bioactivity in tissues is a
result of not only local NO synthase activity, but also the concentration of nitrogen oxide
species which may be delivered from other organs via the blood.
There is accumulating evidence that nitrite plays a role in the regulation of
cardiovascular homeostasis and responses to hypoxic/ischemic stress. Numerous studies
have demonstrated the positive effects of increasing dietary nitrate intake and subsequent
elevation in plasma nitrite concentrations on exercise performance and lowering blood
pressure (5). Modest increases in blood nitrite levels also confer protection in animal
models of ischemia/reperfusion injury in the brain, heart, liver, kidney, and lung (6). The
bioactivity of nitrite results from its conversion to NO by reaction with a number of
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metal-containing proteins with nitrite reductase activity (7), a reaction that is favored in
hypoxic/ischemic tissues.
Infants born prematurely are at increased risk of systemic hypoxia and
compromised cardiovascular homeostasis during the first few days of life. This
dysregulation of tissue oxygen delivery is proposed to contribute to necrotizing
enterocolitis (NEC), a gastrointestinal disease that affects 5 to 14% of infants born
weighing less than 1500 grams (8). While premature birth is a prominent risk factor, the
underlying cause of NEC remains unknown. Although there is little evidence to support
the idea that NEC is caused by a single acute perinatal ischemic event (9), poor
splanchnic oxygenation and reduced blood flow are associated with increased incidence
of NEC (10-12), and histological evidence of ischemia is consistently found (13,14). In
the adult rodent gastrointestinal tract, swallowed salivary nitrite, derived from the
reduction of salivary nitrate by oral bacteria, confers protection by increasing mucus
production, improving local blood flow, killing bacterial pathogens, decreasing
inflammation, and improving epithelial injury (5). The role that nitrate and nitrite play in
regulating gastrointestinal blood flow in the newborn has not been studied.
We have previously demonstrated that newborn infants have lower blood nitrite
concentrations than adults, possibly due to markedly lower levels of nitrate and nitrite
ingestion (15). Preterm infants in particular ingest 50% less nitrite than term infants (15),
leading us to hypothesize that nitrate and nitrite levels would be decreased in preterm
compared to term infants. Furthermore, given animal evidence for the protective effects
of nitrite in the gastrointestinal tract, we hypothesized infants diagnosed with NEC would
have lower levels of circulating nitrite in the days prior to diagnosis. We tested this
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hypothesis by measuring plasma nitrate and nitrite and urine nitrite concentrations in
preterm infants over the first three weeks of life and making comparisons between infants
who developed NEC and those who did not.

Methods
Human protocols were pre-approved by the Loma Linda University (LLU)
Institutional Review Board and written informed consent was obtained from a parent or
legal guardian, or from the study subject (adult group). The animal protocol was preapproved by the LLU Institutional Animal Care and Use Committee.

Human Protocol
The infants studied in this investigation were patients in the neonatal intensive
care unit or well baby nursery of LLU Children’s Hospital (Loma Linda, California).
They fell into two groups: term infants born after 37 weeks and with a birth weight more
than 2500 grams, and preterm infants born at a gestational age less than 32 weeks.
Preterm infants weighing less than 800 grams were excluded from the study due to
limitations in the amount of blood that could be collected. Also excluded were infants
with congenital malformations or chromosomal abnormalities, those small for gestational
age, intrauterine growth restricted, anemic (Hgb < 11 g/dL) or septic (positive blood,
urine, CSF cultures). The infants’ gestational age, birth weight, gender, type of feeding
(breast milk or formula), antibiotic therapy, whether a PDA ligation had been performed,
and whether indomethacin or a blood transfusion had been given were noted.
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Blood and urine samples were obtained from the preterm infants between 12 to 24
hours, and 5, 10, 15, and 20 days of extrauterine life. Within this 20-day period, if an
infant developed signs and symptoms of NEC (defined as Bell’s stage 2A (16)) an
additional sample of blood and urine was collected within 24 hours of diagnosis. Samples
of placental cord blood were collected from term infants following uncomplicated
cesarean section. Blood (1 ml) and urine (1 to 3 ml) samples were also collected from
these term infants in conjunction with standard newborn screening tests at approximately
24 hours of life. Single blood and urine samples were also collected from healthy adults
(24 to 72 years of age).

Fetal Sheep Protocol
Fetal sheep were delivered via C-section at 124 to 126 days of gestation
(term=145) as part of another study protocol (17). Venous blood samples were collected
for plasma nitrite measurement before birth and at 15, 60, 120, and 180 min after ligation
of the umbilical cord. Samples were immediately centrifuged for 60 seconds at 10,000
rpm and the plasma was decanted, frozen in liquid nitrogen, and stored at -80 C for
subsequent measurement of nitrite concentrations.

Sample Collection and Handling
Blood samples (1 ml each) from newborn infants were collected from an
indwelling catheter whenever possible; otherwise by heel stick timed so as to coincide
with routine clinical care (blood glucose measurements, blood gas measurements, weekly
nutrition labs, newborn screen). Blood was collected from adults by venipuncture of the
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antecubital vein. The blood was immediately centrifuged for one minute at 10,000g. The
plasma was stored at -80 C until assay.
Urine samples (1 to 3 ml each) were collected by placing a cotton ball into the
infant’s diaper before urination. Sodium hydroxide (0.1 M) was added to the urine
sample in a 1:1 ratio v/v to stabilize nitrite, and the sample was then stored at -80 C for
subsequent nitrite analysis.

Nitrite and Nitrate Assay
Urine and plasma nitrite concentrations were measured by triiodide
chemiluminescence (18), enabling quantification above 10 nM with a precision of ±5 nM.
Nitrate concentrations were measured by enzymatic reduction of nitrate to nitrite as
previously described (19).

Statistical Analysis
An a priori power analysis was performed using G*Power (Heinrich Heine
University, Dusseldorf, Germany), and indicated that with an effect size of 50%, p<0.05,
and 80% power, a total of six patients with NEC would be needed to detect a change in
plasma and urine nitrite levels over time and compared to preterm controls. Data are
presented as mean ± SEM. Differences between study groups were detected using oneway ANOVA. A two-way ANOVA was used to compare samples from preterm infants
with or without NEC. When ANOVA indicated significance, Bonferroni’s post hoc
analysis was applied to detect differences between sample pairs. A Kruskal-Wallis test
was used to compare term, preterm, and adult plasma nitrite and nitrate levels due to a
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large variation in the small number of samples in the term and adult groups. Outlying
values, likely due to nitrite or nitrate contamination occurring during sample collection,
were identified and removed using the ROUT method (20) with a Q value of 0.1% (0.1%
chance of excluding a valid value). For comparisons between preterm infants with or
without NEC, two-way ANOVA was applied to the Day 1 and 5 data to test whether
nitrite levels were lower in infants who would go on to develop NEC, and to Days 10, 15,
and 20 to test whether nitrite levels were different in infants with developing or active
NEC. All statistical analyses were performed using Prism 6 for Mac OSX (Graphpad
Software, Inc, La Jolla, CA), except for two-way ANOVA with unequal sample sizes
which was performed with R (R Foundation for Statistical Computing, Vienna, Austria).

Results
Nitrite concentrations were measured in blood and urine collected from 79
preterm infants, nine healthy term infants, twelve adults and twelve cord blood samples.
Of the 79 preterm infants, six infants developed Bell’s stage 2A necrotizing enterocolitis.
The time of NEC diagnosis ranged from 9 to 29 days after birth (mean 17 days). Six
preterm infants without NEC developed sepsis and were excluded from analysis because
plasma nitrite and nitrate levels have been shown to be elevated in pediatric and neonatal
patients with sepsis (21-24). One preterm infant died on the 18th day of life with an
isolated ileal perforation and was excluded from the analyses. Thus, 66 preterm infants
without NEC were analyzed. The demographics of the patients are provided in Table 5.
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Table 5. Plasma and urine study preterm patient demographics

Participants (n)
Gestational age
(weeks)
Birth weight
(grams)
Male (n)
Female (n)
Mean day of
diagnosis

Preterm

Preterm with NEC

Term

66

6

9

29.6 ± 0.2

28.1 ± 0.9

38.4 ± 0.3

1349 ± 41

1224 ± 128

2791 ± 282

26

5

4

31

1

5

-

17

-

Nitrite and Nitrate Concentrations in Infant Plasma
Twelve to 24 hours after birth, nitrite concentrations of preterm infants (0.03 ±
0.01 μM) were lower than term infants (0.08 ± 0.01 μM; p<0.05), cord blood samples
(0.18 ± 0.01 μM, p<0.001), and adults (0.16 ± 0.01 μM, p<0.001). Plasma nitrite levels in
term infants tended to be lower than cord blood and adult levels, but post hoc analysis did
not indicate statistical significance. Plasma nitrite concentrations of preterm infants
increased significantly during the 20 days after birth (p<0.001, Figure 19A).
Plasma nitrate concentrations of term infants (16.4 ± 1.5 μM) 12 to 24 hours after
birth were lower than those of preterm infants (25.3 ± 1.7 μM, p<0.05), cord blood
samples (33.1 ± 3.5 μM, p<0.01), and adults (33.4 ± 3.1 μM, p<0.01) (Figure 19B). Oneway ANOVA indicated that there was significant variation in plasma nitrate
concentrations of preterm infants over the first 20 days after birth (p=0.014).
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Figure 19. Plasma nitrite and nitrate and urine nitrite concentrations. A) Plasma nitrite
concentrations were significantly higher in adults, cord blood, and term infants than in
preterm infants on the first day after birth (*=difference from preterm infants on Day 1,
p<0.05). Nitrite concentrations increased over the first 20 days after birth, with Days 10,
15, and 20 greater than Day 1 (**=p<0.01). B) On Day 1, plasma nitrate concentrations
in term infants were significantly lower than those of adults, cord blood, and preterm
infants (* =difference from term infants, p<0.05). The variation in preterm nitrate levels
over the first 20 days after birth was also significant (p<0.01), although post hoc analysis
did not detect a significant difference between Day 1 and any subsequent time point. C)
Urine nitrite concentrations in preterm and term infants on Day 1 were significantly
higher than those of adults (**=p<0.001). Urinary nitrite concentrations of preterm
infants increased over the first 20 days of life, with concentrations on Days 15 and 20
being significantly greater than Days 1 and 5 (* =p<0.05).
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Nitrite Concentrations in Newborn Lambs
The markedly lower nitrite concentrations on the first day after birth led us to
examine the time course of changes in plasma nitrite concentrations in more detail in 13
newborn lambs. Prior to ligation of the cord, plasma nitrite concentration in umbilical
arterial blood was 0.16 ± 0.01 μM. Fifteen minutes after birth, nitrite concentrations had
fallen to 0.06 ± 0.01 μM (p<0.001), and remained low for at least 180 minutes (Figure
20).

Figure 20. Plasma nitrite concentrations in fetal sheep before and after ligation of the
umbilical cord and initiation of ventilation. Within 15 min following birth, nitrite
concentrations had fallen by >60% (*=p<0.001 compared to baseline) and remained
lower than baseline 60, 120, and 180 minutes after birth.

Nitrite Concentrations in Urine
On the first day after birth, urinary nitrite concentrations averaged 0.49 ± 0.05
μM in preterm infants and 0.50 ± 0.05 μM in term infants, values not significantly
different from one another (Figure 19C). The levels in both preterm and term infants on
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Day 1 were significantly higher than the levels measured in urine collected from adults
(0.07 ± 0.01 μM, p<0.001). In preterm infants, the urine nitrite concentrations increased
significantly over the first 20 days after birth (p<0.01, Figure 19C).

Plasma Nitrite and Nitrate Concentrations in Preterm Infants with and without NEC
Plasma nitrite and nitrate concentrations in those preterm infants who developed
NEC were not significantly different than those of control preterm infants on Days 1 and
5. On Days 10, 15 and 20, plasma nitrite concentrations were higher in preterm infants
who developed NEC than in control preterm infants, with post-hoc analysis indicating
significance between the two groups on Days 15 and 20 (p<0.05, Figure 21A and B).
Plasma nitrite concentrations of preterm infants with NEC increased over the first 20
days after birth (p<0.01). Although plasma nitrate concentrations tended to increase in
infants with NEC, this change did not meet the criteria for significance (p=0.09).
Individual and mean plasma nitrite and nitrate concentrations on days relative to
diagnosis with NEC are shown in Figure 22 A-D.

Urine Nitrite Concentrations in Preterm Infants with and without NEC
On Days 10, 15, and 20, plasma nitrite concentrations were higher in the preterm
infants who developed NEC than in control preterm infants, with post hoc analysis
indicating significance on Days 15 and 20 (p<0.01). Urine nitrite concentrations of
preterm infants with NEC increased over the first 20 days after birth (p<0.001) (Figure 21
C). Individual and mean urine nitrite concentrations on days relative to diagnosis with
NEC are shown in Figure 22 E and F.
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Figure 21. Plasma and urine nitrite concentrations in preterm infants with or without
diagnosis of NEC. There were no significant differences between preterm infants with
NEC (black bars) or without NEC (white bars) with respect to plasma nitrite (A) or
nitrate (B) concentrations on Days 1 and 5. In contrast, on Days 10, 15, and 20, plasma
nitrite and nitrate levels were higher in preterm infants diagnosed with NEC compared to
those without NEC. C) Fifteen and 20 days after birth, urine nitrite concentrations in
preterm infants who developed NEC were significantly higher than those of control
preterm infants (*=p<0.001). Nitrite concentrations in urine from the preterm infants with
NEC increased over the first 20 days after birth, with levels on the day they were
diagnosed with NEC (mean=Day 17) being significantly higher than the levels measured
in these infants on Days 1 and 5 (**=p<0.05). (*=difference from non-NEC infants at the
same time point, p<0.05; †=difference from Day 1, p<0.05).
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Figure 22. Plasma nitrite and nitrate concentrations and urine nitrite concentrations in
preterm infants with a diagnosis of NEC. X-axis shows days relative to the day of
diagnosis with Bell’s Stage II NEC (Day 0). Each curve represents an individual patient
in figures A, C, and E, where NEC 1 (●), NEC 2 (■), NEC 3 (●), NEC 4 (■), NEC 5 (□),
and NEC 6 (●). Figures B, D, and F are the mean (± SEM) data from all patients with
NEC ( ).
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Discussion
The current study tested the hypotheses that plasma nitrite levels fall significantly
at birth, that levels in preterm infants fall below those of term infants, and that infants
diagnosed with NEC would have lower levels of circulating nitrite in the days prior to
diagnosis. We found that the plasma nitrite concentrations of preterm infants on the first
day of life were lower than those of term infants, adults and placental cord blood, a
difference also observed to appear in newborn lambs within 15 minutes after birth.
Contrary to our hypothesis, plasma and urine nitrite levels of preterm infants who
developed NEC were similar to those of their non-NEC counterparts on Days 1 and 5
after birth. Once NEC became apparent, plasma and urine nitrite concentrations were
measurably higher than those of non-NEC counterparts 15 and 20 days after birth.

Decrease in Plasma Nitrite and Nitrate Concentrations at Birth
Several reasons might account for the marked decrease in plasma nitrite in the
minutes and hours after birth. Previous studies have shown that up to 70% of plasma
nitrite is derived from NO produced by eNOS (25). Several studies have assessed the
effects of development on organ-specific eNOS levels (26, 27), but, to our knowledge
none have measured whole body eNOS activity in newborns. Preterm infants are
deficient in arginine which could lead to decreased NO synthesis from eNOS (28).
Neonates also have two- to threefold higher concentrations of asymmetric
dimethylarginine (ADMA), an endogenous inhibitor of NOS, compared to adults (29).
Thus, low L-arginine and increased ADMA concentrations may lead to low eNOS
activity in newborns, contributing to the fall in plasma nitrite levels after birth.
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It is also possible that the mother and placental tissue constitute a significant
source of fetal nitrite that is lost at birth. We have previously reported that nitrite
concentrations of chronically instrumented fetal sheep are the same as those of the
mother under normoxic conditions, but become two-fold higher than the ewe following
long term exposure to moderate hypoxia (18). This finding suggests transport of nitrite
from the ewe into the fetus, production of nitrite by placental tissue, or an accelerated rate
of nitrite production in the fetus in response to hypoxia. These possibilities have not been
evaluated experimentally but could influence the changes that occur soon after birth.
Although most plasma nitrite is derived from NO oxidation, this reaction is only
one of a number of competing reactions by which NO is consumed. One of the fastest of
these competing pathways is the reaction of NO with superoxide to form peroxynitrite.
This reaction proceeds at a nearly diffusion-limited rate (k = 4.3 to 20 × 10 9 M -1 ∙s-1) (30)
and can become a significant scavenger of NO if superoxide concentrations are increased
(31). While we are not aware of reported changes in whole body superoxide levels at
birth, it is reasonable to hypothesize that the increases in arterial and tissue oxygen
tensions that occur in the transition from fetus to newborn increase superoxide production
that, in turn, scavenges NO away from nitrite production.
Regardless of the mechanism, the fall in nitrite levels at birth appears to be
consistent with other cardiovascular homeostatic events that facilitate the vascular
transition from a fetal state characterized by low pressures and high flows to a newborn
state with higher overall resistance to blood flow. Factors that contribute to the increased
vascular tone of the newborn include decreases in circulating vasodilators such as
prostaglandin E2 (32) and adenosine (33), and increases in vasoconstricting
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catecholamines (34). Given the vasodilatory and NO-like bioactivity ascribed to nitrite
(see review by Lundberg and Weitzberg (4)), the fall in concentrations within minutes of
birth raises the possibility that nitrite may also play a role in the transition.
While circulating nitrate concentrations are of cardiovascular relevance to the
adult due to its conversion to nitrite (35), the same may not be true for newborns as the
activity of oral nitrate-reducing bacteria is markedly reduced (3). Plasma nitrate
concentrations tended to decrease at birth, in parallel with nitrite concentrations, although
the changes were less pronounced in the preterm infants. This may reflect the
contribution of non-NO-related influences, such as denitrifying enzymes in the liver (36)
or decreased renal excretion.

Nitrite Concentration in Urine
Although there are numerous reports of combined nitrite/nitrate concentrations in
newborn urine (see Honold et al for comprehensive measurements (37), we are unaware
of previous reports of urine nitrite levels in healthy infants. Urinary nitrite concentrations
are typically less than 5% of the total nitrite/nitrate signal, thus the combined nitrite and
nitrate level is not a useful indication of nitrite excretion. In fact, in contrast to our
finding of higher urinary nitrite levels in infants compared to adults, Honold et al.
reported higher urinary nitrite/nitrate concentrations in adults compared to preterm and
term infants (37). Using the body weights of our infants and estimates of normal urinary
output (48 mL·kg-1·day-1), one may calculate a urinary nitrite output for preterm infants
of 3.6 µg·kg-1·day-1 and for term infants of 5.3 µg·kg-1·day-1. A similar calculation for a
typical 70 kg adult with a urine output of 12 mL·kg-1·day-1 indicates a urinary nitrite
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output of only 0.24 µg·kg-1·day-1, about 5-10% of newborn output. This marked
difference between newborns and adults cannot be explained by dietary intake, since
newborns ingest less than 1% as much nitrite as adults when normalized to body weight
(38). Interestingly, for newborns the urinary excretion of nitrite is significantly higher
than their estimated dietary intake (~0.7 µg·kg-1·day-1) (38), whereas excretion by adults
is less than intake (109 µg·kg-1·day-1) (39). This result suggests net endogenous
production of nitrite by newborns and consumption by adults. Nitrite is actively
reabsorbed in the kidney of adults via a pathway dependent upon carbonic anhydrase
activity (40), and a deficiency in this pathway in newborns would also contribute to
higher urinary nitrite levels, although this possibility remains to be studied.

Possible Role for Nitrite in NEC
Various lines of evidence suggest NO and nitrite potentially play a protective role
against NEC. L-arginine supplementation to promote eNOS activity has been shown to
reduce the severity and risk of NEC (41, 42). Nitrite, serving as a source of NO, protects
against ischemia/reperfusion injury in a number of organs and animal models (6). In the
gastrointestinal tract, NO derived from nitrite also protects against bacterial pathogens
and supports thickening of the protective mucosal layer, and thus may support the barrier
function of the gastrointestinal lining (5). Supplemental dietary nitrite is also protective in
a mouse model of NEC (43). Thus, our hypothesis was that preterm infants with lower
plasma nitrite levels during the first few days of life would be more likely to develop
NEC. However, plasma nitrite levels of preterm infants destined to develop NEC were
similar to healthy preterm controls, indicating that NEC is not caused by plasma nitrite
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levels that are lower than normal for a preterm infant. Notably, plasma nitrite levels were
already markedly lower in preterm infants than in term infants and adults, and whether
supplementation of nitrite would be protective requires further study.
In contrast to the proposed beneficial effects of nitrite and NO under
physiological conditions, it appears that once NEC has reached an acute inflammatory
stage, it has been postulated that excessive NO production from inducible NOS (iNOS)
contributes to the disease progression (44). Resected sections of intestine from infants
with acute NEC have increased levels of iNOS and iNOS knockout mice appear to be
protected against LPS-induced bacterial translocation (45). Overproduction of NO by
enhanced iNOS activity leads to toxic levels of reactive nitrogen oxide derivatives, like
peroxynitrite, that are thought to contribute to the epithelial injury and disruption of
repair mechanisms that lead to intestinal barrier failure characteristic of NEC (46).
Consistent with overproduction of NO by iNOS, plasma nitrite and nitrate and urinary
nitrite levels in infants developing NEC became significantly elevated fifteen and twenty
days after birth (Figure 21), suggesting that urinary nitrite levels could be a useful noninvasive biomarker of NEC. However, more rigorous studies need to be done to validate
nitrite as a reliable marker for NEC. While the cause of this increase cannot be
determined from the present study, it is worth noting that similar increases in urinary
nitrite and/or nitrate are found in infants with systemic inflammatory responses (47),
consistent with markedly increased iNOS activity.
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Clinical Perspective
The current study finds that a marked fall in circulating nitrite concentrations
occurs at birth. Given increasing evidence that nitrite plays a key role as a circulating
source of NO, future studies are needed to establish the extent to which changes in nitrite
concentrations contribute to the cardiovascular transition at birth, and whether
manipulation of these concentrations might improve outcomes in infants exposed to
hypoxic/ischemic stress.
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CHAPTER FIVE
DISCUSSION
The discovery that nitric oxide (NO) is produced endogenously by NO synthases
initiated a paradigm shift from thinking of NO as a toxic gas to the realization that it is a
key regulator of vascular homeostasis, amongst many other physiological roles. One of
the greatest clinical impacts of this discovery has been the use of inhaled NO gas for the
treatment of persistent pulmonary hypertension in newborns where it has significantly
reduced the need for extracorporeal oxygenation (1-2). Initially it was thought that the
effects of inhaled NO would be confined to the lungs, as free NO gas in blood is
scavenged by reactions with hemoglobin in a few milliseconds (3). However, it is now
widely reported that inhaled NO has an array of extrapulmonary effects, suggesting that
one or more of its metabolites serve as reservoirs of NO bioactivity capable of circulating
from the lungs to peripheral organs. The existence of such an endocrine mediator of NO
and its effects would be of great physiological relevance and much recent research has
focused on identifying metabolites of NO that may serve in that role.
Nitrate (NO3-) and nitrite (NO2-) are the two major end products of NO
metabolism. Historically, these compounds were considered to be relatively inert at
physiological concentrations and environmental pollutants that posed potential health
risks to humans at high concentrations. However, similar to the turnabout course of our
understating of NO in biology, evidence now indicates that while nitrate and nitrite may
be toxic at high concentrations, they play an important physiological role as they can be
converted back into NO via a system involving enterosalivary recirculation, bacterial
nitrate reductases, and enzyme-catalyzed or acidic reduction of nitrite to NO. This
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discussion will summarize our current knowledge regarding the bioactivity of nitrate and
nitrite in adults and will outline known differences in infants (summarized in Figure 23
and Table 6).

Figure 23. Schematic summary showing major differences in the supply and handling of
nitrite and nitrate by the adult and infant. Multiple deficiencies in the infant lead to
diminished nitric oxide (NO) bioactivity in the stomach and lower circulating nitrite
concentrations in the blood.
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Table 6. Summary of the major differences in the supply and handling of nitrite and
nitrate in adults and infants
Adults
Infants
References
Dietary nitrate
ingestion

0.88-5.83 mg·kg 1
·day -1

Saliva nitrate
concentrations

190-1600 µM

0.07-2.065 mg·kg 1
·day -1

a

190-1600 µM

681 ± 184 µM b
Saliva nitrite
concentrations

a

284 ± 83 µM b

90-670 µM a

4-8

9-13
14
9-13

50 ± 13 µM b

8.2 ± 5.6 µM b

14

43-1728 mL/day

43-58 mL/day

15

147 ± 36 nmoles·min1
·mg saliva -1

20 ± 8 nmoles·min1
·mg saliva -1

14

Stomach pH

1.5-3.5

3-6

15-18

Gastric NO
production

16.4 ± 5.8 ppm c
89.4 ± 28.6 ppm d

Saliva production
Oral bacterial nitrite
production

Plasma nitrite
concentrations
Urinary nitrate/mmol
creatinine
a

19
1.53 ± 3.1 ppm

20

0.27 ± 0.01 µM

0.18 ± 0.01 µM

21

71 ± 10/75 ± 11
µmol nitrate/mmol
creatinine

150 ± 31/136 ± 28
µmol nitrate/mmol
creatinine

22

b

c

d

Saliva collected via expectoration Saliva collected via oral swab Basal After dietary nitrate load

Diet
Dietary Nitrate and Nitrite
Nitrate is the most prevalent nitrogen oxide species in the body. Although some of
it is derived as an end product of the oxidation of endogenous nitric oxide and nitrite,
nitrate concentrations are also heavily influenced by dietary intake. Nitrate itself is inert
in mammalian tissues, but it can be reduced to nitrite by symbiotic bacteria that are part
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of the normal flora in the mouth and gastrointestinal tract (discussed below). Thus, by the
action of these bacteria, dietary nitrate contributes to the body’s pool of nitrite.
Vegetables are the most common source of dietary nitrate with particularly high
concentrations (>2500 mg/kg) in beets, radishes, celery and green leafy vegetables such
as lettuce, kale, and spinach. Although daily nitrate ingestion can vary significantly
dependent upon the types and amount of vegetables eaten, it is estimated that a typical
adult ingests approximately 0.7 to 3.0 mg/kg body weight of nitrate per day (23).
Compared to nitrate, the amount of nitrite ingested in a normal adult diet is
relatively small. In fact, it is likely that more of the nitrite in the body is derived from the
bacterial reduction of nitrate and oxidation of endogenously-produced NO than from the
diet (24, 25). The biggest source of nitrite in the diet is cured and processed meats, where
it is used as an additive to prevent bacterial growth and enhance the color. A typical adult
ingests about 0.1 mg/kg body weight of nitrite daily (4).
Although there are some discrepancies in the reported concentrations of nitrate
and nitrite in breast milk and artificial milk (perhaps due to differing assay
methodologies), we and others have recently shown that newborn infants ingest markedly
lower amounts of nitrate and nitrite than adults on a per kg body weight basis. This is true
regardless of whether they are receiving breast milk, artificial milk, or parenteral nutrition
(7, 26, 27). Based on a breast milk intake of 150 mg•kg-1•day-1 and our measurements of
nitrate and nitrite concentrations (13 μM and 0.13 μM, respectively), we have estimated
that infants ingest approximately 0.12 mg•kg-1•day-1 of nitrate and 0.0007 mg•kg-1•day1

of nitrite from fresh breast milk, which equates to only 5% and 0.6% of the nitrate and
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nitrite intake of adults (27). A comparison of the average dietary nitrate intake in
newborn infants and adults is shown in Figure 24.

Figure 24. Dietary nitrate and nitrite levels for newborns and adults. A) Daily dietary
nitrate ingestion, normalized for body weight, is shown for newborns and adults, based
on a mean (±SEM) of reported concentrations in breast milk and formula (for newborns)
(7, 26, 27) and a typical adult diet (Mensinga). B,C) Nitrate and nitrite concentrations in
total parenteral nutrition (TPN), fresh and freeze-thawed breast milk, freeze-thawed
colostrum, and a convenience sample of artificial milk formulas. (Figure adapted from
Jones et al., 2014 (27).)

We have also shown that nitrite is oxidized to nitrate in breast milk by an enzyme
normally present in milk, lactoperoxidase, leading to even lower levels in milk that has
been allowed to sit at room temperature or which has been freeze-thawed (27). Breast
milk nitrite concentrations also fall during the first few weeks of life, with the highest
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levels found in colostrum and decreasing to nearly undetectable amounts in milk
collected after the third week postpartum (26, 27). The levels of nitrate and nitrite in
artificial milk vary widely across a range that extends above and below concentrations
measured in breast milk, averaging 43 μM and 0.3 μM, respectively (27) (Figure 24). The
recently increased use of nutritional additives for caloric and protein enhancement raises
the possibility of an additional source of dietary nitrate and nitrite, although to our
knowledge concentrations in these additives have not yet been reported. Whether the
newborn deficiency of dietary nitrite and nitrate serves an important physiological role,
or whether supplementation of breast milk with these anions would be beneficial or
problematic remains to be studied.
Until recently, a majority of research related to dietary nitrate and nitrite was in
the context of toxicology. It has been known since 1945 that unusually high nitrate
concentrations in vegetables and drinking water, often due to contamination with
fertilizer, can cause cyanosis due to oxidation of hemoglobin to methemoglobin by nitrite
derived from bacterial nitrate reductases, a problem often referred to as “blue baby
syndrome.” Newborn infants are particularly susceptible to this problem as they have
~25% lower methemoglobin reductase activity than adults (28). It is also proposed that
dietary nitrate and nitrite are associated with gastrointestinal cancer due to the formation
of carcinogenic N-nitroso compounds. Although a definitive causal link between dietary
nitrate and cancer has not been identified (29), the associations between the intake of
nitrite-treated meats and gastric cancer are more established (30). This is consistent with
evidence that nitrite added to meats as a preservative can be converted to harmful Nnitrosamines in the meat itself before ingestion or in the body after it has been ingested
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(31). In an effort to protect against toxicity, the Environmental Protection Agency (EPA)
has set limits on inorganic nitrate and nitrite levels in drinking water and the World
Health Organization (WHO) has put forward Acceptable Daily Intakes (ADI) for nitrate
at 3.7 mg/kg of body weight and for nitrite at 0.06 mg/kg of body weight. These levels
are easily exceeded, however, with a high vegetable diet, and some have called for a
resetting of these limits based on recent advances in our understanding of the roles of
dietary nitrate and nitrite (26). The upper limits of toxicity of dietary nitrate in newborns
have been investigated. Phillips, et al. found that up to 21 mg/kg of nitrate per day was
well tolerated by seven newborn infants, with six infants showing no increase in
methemoglobin and the other one only a slight increase, and not enough to produce
detectable cyanosis. Likewise, no symptoms of cyanosis occurred even when 100 mg
nitrate •kg-1•day-1 was given to an infant for 8 days (32).
In contrast to the evidence of the toxic effects of nitrate and nitrite, the data
increasingly indicates that a diet rich in nitrate is beneficial to overall cardiovascular
health. In adults, raising dietary nitrate intake has been shown to improve exercise
tolerance (30, 33, 34), decrease blood pressure (24, 34), inhibit platelet aggregation (24),
decrease risk of cardiovascular disease (35), and improve vascular compliance (36) (see
Weitzberg, 2013 for a comprehensive review) (37). In addition, nitrite supplementation
ameliorates microvascular inflammation and endothelial dysfunction in mice fed a highcholesterol diet (38). Dietary nitrate also appears to have beneficial effects in the
gastrointestinal tract of adult rats, where it has been shown to protect against nonsteroidal anti-inflammatory drug (NSAID)-induced ulcers (39). Weighing the beneficial
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effects of increasing dietary nitrate and nitrite (37) against the potential risks of
methemoglobinemia and carcinogenicity is the focus of ongoing studies.

Saliva
In addition to dietary intake of nitrate and nitrite, the levels of these anions in
swallowed saliva also have a significant impact on the amount of nitrate and nitrite that is
ingested. As discussed in this section, this appears to be another point of significant
difference between adults and newborns, thus compounding the effects of low dietary
nitrate and nitrite ingestion in newborns.

Bacterial Conversion of Salivary Nitrate to Nitrite
Fasting nitrate concentrations average about 200 µM in the saliva of adults but
can reach as high as 10 mM after a nitrate-rich meal (12). These concentrations are
approximately 10-fold higher than the concentrations measured in plasma due to active
transport of nitrate from the blood into the saliva by the salivary glands. The transport of
nitrate has been suggested to be mediated by the enzyme sialin via an ATP-dependent
electrogenic NO3-/H+ transport mechanism in the salivary acinar cells (40). The nitrate
concentration in the saliva of newborns is approximately 200 µM, similar to that of adults
(14). As in adults, this concentration is many-fold higher than in blood (16-40 µM). Thus
the active transport mechanisms in the salivary glands of newborn infants are present
with a concentrating power comparable to that of adults (21, 41). That the body expends
energy to actively concentrate nitrate into the saliva suggests that nitrate is not just an
inert end product of NO metabolism, but has potential bioactivity in the body.
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Although nitrate itself appears to be inert in mammalian tissues, it is made
physiologically relevant after reduction to nitrite by bacteria residing in the crypts of the
dorsal posterior surface of the tongue. These bacteria utilize nitrate as the terminal
electron acceptor in the respiratory chain, rather than oxygen and reduce about 20% of
salivary nitrate in adults (30, 42). A true symbiotic relationship between these bacteria
and the human host exists as humans lack the requisite enzymes to bring about this
conversion independently but provide nitrate to the bacteria that then perform nitrate
reduction via respiration. As discussed below, these nitrate-reducing bacteria are critical
to the beneficial effects of dietary nitrate.
The primary bacteria that mediate nitrate reduction in the mouth are obligate
anaerobes of the Veillonella species and facultative anaerobes of the Actinomyces,
Rothia, and Staphylococcus species, all of which possess nitrate reductase enzymes that
allow them to respire nitrate and rapidly produce nitrite (43). Veillonella and Actinomyces
species have been found in saliva collected from infants in the first two months of life
and appear to be some of the first bacteria to colonize the mouths of newborns (12, 4446). Despite the presence of these bacteria, oral nitrate reductase activity is markedly
lower in newborn infants when compared to adults, as shown in Figure 25. It is unknown
whether this difference comes from insufficient numbers of bacteria, whether the bacteria
do not possess sufficient nitrate-reducing capacity, or whether the mouth of newborns
lack some cofactor for nitrate reduction or some other necessary element.
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Figure 25. Nitrate-reducing activity, normalized for saliva weight, in swab samples
collected from the mouths of preterm (born at <35 wk gestation) and term (born at >36
wk) infants in the neonatal intensive care unit (NICU) or from healthy infants in an
outpatient clinic between 2 and 6 wk after birth, or from normal healthy adults.
Mammalian cells lack the enzymes required for nitrate reduction, but bacteria dwelling in
crypts of the tongue bring about the reaction. Note that the rate in infants is ~10% of that
in adults. (Figure adapted from Kanady et al., 2012 (14).)

By measuring the nitrate-reducing capacity of bacteria in oral swabs collected
from infants, we have shown that there is essentially no detectable nitrite production from
nitrate in the first five days of life. While there is measurable nitrate reducing capacity in
swabs collected from infants at two to eight weeks of age, the rate of nitrite production is
only ~10% of that of adults (14), as illustrated in Figure 25. Notably, infants also produce
relatively small volumes of saliva during the first few weeks of life, which may attenuate
bacterial growth and may also result in less swallowed salivary nitrite compared to the
adult (14). The developmental time point at which the nitrate reducing capacity of the
infant mouth becomes comparable to the adult is unknown.
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The diminished bacterial nitrate reducing capacity in infants may be of
physiological relevance because salivary nitrite impacts both gastrointestinal and
cardiovascular function in adults. Blockade of salivary nitrate secretion by ligation of the
submandibular gland duct in rats results in decreased gastric nitrate, nitrite, and NO
concentrations and exacerbates stress-induced gastric ulcers (47). The severity of gastric
ulcers in these rats is reduced upon supplemental nitrate treatment (47). These
gastroprotective effects appear to be mediated through the action of increased salivary
nitrite, as nitrite-rich saliva results in increased gastric mucosal blood flow, a thicker
mucus layer, and attenuation of the inflammatory response associated with NSAID
administration in rats (39, 48-49). These effects of nitrite on the stomach are likely due to
its conversion to NO, as discussed below.
In addition to the effects in the gastrointestinal tract, increasing dietary nitrate,
and concomitant increases in salivary nitrite, have been shown to decrease arterial blood
pressure, protect against ischemia-reperfusion induced endothelial dysfunction, and
decrease platelet aggregation (24, 34). The importance of salivary nitrite production by
oral bacteria is again highlighted by the finding that if subjects refrain from swallowing
saliva after a dietary nitrate-load or are given antibacterial mouthwash to decrease
bacterial nitrate-reducing activity, the hypotensive effects of nitrate are attenuated and
there is no inhibition of platelet aggregation (24, 50). Increasing dietary nitrate also leads
to increased circulating nitrite concentrations (24), which is associated with a host of
beneficial effects ranging from improved exercise tolerance to protection against
ischemia-reperfusion injury (discussed below).
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Thus, considering the beneficial gastrointestinal and cardiovascular effects of
dietary nitrate and subsequent salivary nitrite production by oral nitrate reducing bacteria
in adults, the lack of the critical bacterial nitrate reduction in infants is noteworthy and
deserves investigation. Moreover, the lack of bacterial nitrate reducing activity in infants
will compound the already low levels of nitrate and nitrite in their diet, ultimately leading
to significantly lower nitrite delivery to the infant stomach. The potential benefit of
adding a mother’s oral bacteria to an infant’s mouth is untested.

Gastrointestinal tract
Intragastric Conversion of Nitrite to NO
In 1994, two independent studies showed that NO was generated from nitrite in
the stomach of human adults (51, 52). These studies showed a novel nitric oxide synthase
(NOS)-independent in-vivo mechanism by which NO could be generated from nitrite.
Since then, there has been great interest in nitrite as not merely an inert NO metabolite
but as a physiologically relevant source of NO bioactivity. The chemical reaction by
which NO is generated in the acidic stomach of adults involves protonation of nitrite to
form nitrous acid (pKa 3.3), which rapidly decomposes to several highly reactive
nitrogen oxides, including NO free radical, NO2, N2O3, and peroxynitrite (51, 53). In the
stomach, these nitrogen oxides can form new stable products through nitration and
nitrosylation of amines, amides, thiols, and fatty acids. These products have wide-ranging
bioactivities, which include modulation of inflammatory signaling pathways, inhibition
of platelet aggregation, vasodilation, mucus production, and bacterial colonization,
among many other functions (53-56).
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Via gastric conversion to NO, ingested nitrite has been shown to kill many
different enteropathogens including Salmonella, Shigella, H. pylori, E. coli, Yersinia
enerocolitica, C. difficile and Candida albicans, establishing nitrite as a key player in
host defense (57-60). In addition to acting as a bactericidal agent, NO plays a key role in
host defense in the gastrointestinal tract by stimulating mucus and fluid secretion,
regulating the epithelial barrier, mediating vascular smooth muscle tone, diminishing
leukocyte adherence to the endothelium, modulating mucosal repair, and influencing the
release of inflammatory mediators (57,61). While it is now apparent that nitrite-derived
NO plays many protective roles in the stomach and GI tract, it is important to note that
nitrite in the stomach (via conversion to nitrous acid and other nitrogen oxides) can also
act as a nitrosating agent, converting ingested amines into their carcinogenic N-nitroso
derivatives (30). However, while the nitrosating ability of acidified nitrite is clear, there is
still no direct evidence that increased ingestion of nitrate, and subsequent conversion to
salivary nitrite and gastric NO, causes increased risk of gastric cancer (42).
NO generation from nitrite in the stomach is highly pH dependent and is
effectively attenuated with proton pump inhibitors (52). Consequently, the protective
effects of swallowed nitrite appear to be highly dependent upon gastric acidity as
increasing the pH above a value of 4 effectively prevents nitrite-induced increases in
blood flow (48) and reduction in pathogenic bacteria (51, 60), and blocks nitrite’s
hypotensive effects (62).
The pH dependence of nitrite-derived gastric NO is of particular relevance in the
newborn, as the newborn stomach has a relatively high pH compared to the adult stomach
(17, 18, 63). Figure 26 illustrates the effect of pH on the rate of NO production from
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nitrite using previously calculated rate constants (64). As shown in Figure 26, the less
acidic environment of the newborn stomach would attenuate the generation of NO from
nitrite delivered to the stomach, compounding the already low nitrite ingestion from the
saliva and diet. In fact, non-enzymatic NO production in the stomachs of newborns
averages 1.53 ± 3.10 ppm (20), as compared to 16.4 ± 5.8 ppm in fasted adults (19) or
89.4 ± 28.6 ppm after a 2 mmol nitrate load (19). However, reports vary as to the
quantitative amount of stomach NO generation in adults, which are also reported as low
as 0.6 ± 0.1 ppm in fasted adults and 1.64 ± 0.4 ppm after dietary nitrate intake (52).
Interestingly, peak gastric NO generation is shown to be lower in formula-fed infants
(2.24 ± 15.71 ppm) versus breastfed infants (6.03 ± 5.73 ppm) (20). Further work should
be done to explore these intriguing findings.
High gastric pH in newborns has been associated with an increased risk of
necrotizing enterocolitis (NEC) (65, 66), whereas low gastric pH protects against
bacterial translocation across the gut wall in neonatal rabbit pups (67). Considering that
acidified nitrite kills bacteria, improves mucus secretion and mucosal blood flow, and is
protective against ischemia-reperfusion injury (discussed below), it is worth speculating
that enhancing NO generation from nitrite would be protective against NEC.
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Figure 26. Nomogram showing the rate of nitric oxide (NO) generation in gastric fluid
for various pH and nitrite concentrations. The adult and newborn ranges of nitrite
concentrations are shown as box and whisker (min to max) plots of saliva nitrite
concentrations (14) and placed at reported typical ranges of gastric pH for adults and
newborns (18). The infant rate is estimated to be about 100-fold slower than the adult rate
due to less acidity in the newborn stomach and lower nitrite levels ingested. Curves were
constructed using rate constants and equations given by Zweier et al. (64).

Intestine
In contrast to the NOS-independent generation of NO in the stomach, NO
generation in the colon appears to be mediated by NOS-dependent mechanisms, as
demonstrated by the finding that rats treated with the NOS inhibitor NG-nitro-L-arginine
methyl ester (L-NAME), have significantly less NO generation in the colon while NO
generation in the stomach is unaffected (68). In rats, NO concentrations in the stomach
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(>4000 ppb) are orders of magnitude higher than in the small intestine (<20 ppb), cecum
(~200 ppb), or colon (<25 ppb) (68). Interestingly, germ-free rats have markedly lower
NO generation in all areas of the gastrointestinal (GI) tract, including the stomach,
indicating an important role for bacteria in NO production throughout the GI tract. Germfree rats provide a useful comparison to newborn infants, as diminished gastric NO in
germ-free rats is thought to be due to the lack of oral nitrate reducing bacteria since
gastric NO production is dependent on substrate (ingested nitrite) availability (68). In the
cecum, NO is in part formed via reduction of nitrate and nitrite by strains of Lactobacilli
and Bifidobacteria (69) and stimulation of the mucosal NOS enzymes by GI bacteria
(68). NO generation in the intestine, either by Lactobacilli farciminis or by administration
of an NO-donor, has been demonstrated to have anti-inflammatory effects in an animal
model of colitis (70), highlighting the potential protective effects of increased NO
generation in the intestine.
Given the beneficial effects of NO derived from ingested nitrite on the
gastrointestinal microbiota, blood flow and mucus production (described above), we were
interested in nitrite’s role in the context of NEC. NEC is the most common
gastrointestinal disease to afflict premature infants. It is a disease characterized by
intestinal barrier failure (71) most likely subsequent to an ischemic insult. The main
factors contributing to the regulation of gastrointestinal blood flow in the preterm infant
are poorly defined, and it is not known whether a deficiency in NO contributes to the
dysregulation of gastrointestinal blood flow that is thought to precede NEC. Thus, we
hypothesized that infants with NEC would have lower circulating nitrite levels (and thus
lower NO bioavailability) in the days preceding the onset of NEC. However, we found
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that abnormally low plasma nitrite levels do not appear to predispose infants to NEC.
Yet, active NEC (Bell’s Stage II, diagnosable by radiographic signs (72) is associated
with elevated plasma and urinary nitrite levels.
Translocation of bacteria across the compromised gastrointestinal wall leads to
activation of an inflammatory response characterized by pronounced up-regulation of NO
production by inducible NOS (iNOS). In this inflammatory stage of the disease,
overproduction of NO by iNOS results in toxic levels of peroxynitrite, further damaging
the integrity of the gut wall by inducing enterocyte apoptosis and necrosis, or by
disrupting tight junctions and gap junctions that normally maintain epithelial monolayer
integrity (73, 74). Thus, a vicious cycle characteristic of severe NEC is created by
bacterial invasion, immune activation, uncontrolled inflammation with production of
ROS and nitrogen species, vasoconstriction followed by ischemia-reperfusion injury, gut
barrier failure, intestinal necrosis, sepsis and shock (75). Since NEC is predominantly
found in preterm infants, and preterm infants have significantly lower plasma nitrite
levels than term infants (0.03 ± 0.01 μM vs. 0.08 ± 0.01 μM; p<0.05), it would appear
reasonable to hypothesize that NO plays a dichotomous role in NEC, with deficient levels
of NO contributing to an increased vascular resistance during the initiating ischemic
event, and subsequent overproduction of NO during the inflammatory stage of the disease
leading to propagation of the injury. Interestingly, Yazji et al have recently reported that
nitrite/nitrate-deficient formula predisposes newborn mice to NEC, and that both the
incidence and severity of NEC was ameliorated by nitrite/nitrate supplementation to the
formula to achieve levels comparable to that of breast milk (76). However, the clinical
relevance of this finding is uncertain given the fact that nitrite and nitrate concentrations
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of many commercially available formulas are already higher than those found in breast
milk (27). Whether manipulation of the decreased levels of ingested and circulating
nitrite in the preterm infant would prevent or alter the course of NEC is an area worthy of
study.

Nitrite Supplementation for the Prevention of NEC in Newborn Rat Pups
To test whether nitrite supplementation would be protective against NEC, we
utilized a newborn rat pup model of NEC, based on that described by Nadler et al. (77).
In this model, neonatal rats are removed from their mothers after Caesarian-section,
placed in a humidity and temperature-controlled incubator, gavage-fed formula in lieu of
breast milk, and exposed to hypoxia (5% O2, 95% N2) twice daily. Littermate controls are
placed with a foster dam and allowed to breast feed ad lib and are not exposed to
hypoxia. Using this model, we sought to test the efficacy of nitrite (0-3mM) in preventing
intestinal damage by evaluating the ileum for signs of NEC. Tissue sections were given a
score from 0 (healthy) to 4 (severe NEC), with a score of 2 or greater indicating NEC.
We also evaluated the tissue for macroscopic evidence of pnuematosis intestinalis and
bowel discoloration.
Although this model is used in multiple labs throughout the country and has been
helpful in elucidating many of the molecular pathways involved in NEC pathogenesis, its
clinical relevance is limited given that NEC typically manifests 2-4 weeks after birth,
rather than in the first 72 hours after birth as designed in this experimental model (78). In
addition to this inherent problem with the model, we experienced difficulty in being able
to reliably reproduce histological NEC in the pups, as determined by two independent
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clinical pathologists blinded to the study conditions. Thus, it was impossible to form
conclusions about nitrite’s efficacy against NEC since NEC could not be shown to be
induced.
Through the use of this model, however, we found that the mean histological
score of 34 pups that did not receive supplemental NO2- (formula-fed (FF) + hypoxia)
was significantly worse than that of the healthy control group (0.5 ± 0.08 vs. 0.23± 0.03,
respectively) (p<0.01, ANOVA). The histological scores of the pups that received nitrite
were not significantly worse than the healthy controls. However, they were not improved
compared to the FF + hypoxia group (Figure 27). Furthermore, nitrite treatment had no
effect on the survival rates, weight gain, severity of pneumatosis intestinalis, or intestinal
discoloration. Based on the histological scores, nitrite may offer some protection against
the early stages of intestinal damage. However, the other points of evaluation suggest the
preventative effects of nitrite are minimal. Moreover, the scores for the FF + hypoxia
(“NEC” positive control) group did not reach the threshold for NEC and thus, nitrite’s
efficacy in preventing NEC remains untested.
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Figure 27. Histological scores of ileum samples collected from neonatal rat pups exposed
to formula feeding (FF) with increasing doses of nitrite (0-3 mM) and hypoxia twice
daily for 72 hours.

Circulation
Circulating Nitrite
Shortly after the discovery that NO is generated from nitrite in the acidic
environment of the stomach, Zweier and colleagues showed that NO could also be
generated from nitrite in ischemic heart tissue (79). Nitrite reduction to NO in hypoxic
tissues appears to be mediated either by acidic disproportionation (similar to the
mechanism in the acidic stomach) or by the activity of metal-containing proteins with
nitrite reducing activity. These proteins include the heme-associated globins in their
deoxygenated state, such as deoxygenated myoglobin, hemoglobin, cytoglobin and
neuroglobin, as well as mitochondrial enzymes like complex III; molybdenum
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metalloenzymes, such as xanthine oxidoreductase (80); cytochrome P450 enzymes; and
endothelial NOS (see the review by Kim-Shapiro and Gladwin) (81). While the initial
report by Zweier suggested that nitrite reduction to NO in acidic tissues exacerbates postischemic injury (79), nitrite has since been consistently shown in experimental animals to
be protective against ischemia-reperfusion (I/R) injury in the heart, brain, liver and
kidney (82). The mechanism by which nitrite confers protection against I/R injury is not
well understood, but is thought to involve reduction to NO which modulates the function
of the mitochondria, leading to more efficient oxygen utilization, decreased reactive
oxygen species formation, and the inhibition of apoptotic signaling (83). The therapeutic
potential of nitrite against I/R injury in newborns has not yet been studied. Considering
that neonates are particularly at risk for hypoxic and ischemic insults, further research is
needed to address the therapeutic and preventative potential for nitrite supplementation in
the neonatal population.
While nitrite supplementation has yet to be studied in neonatal populations, it has
been shown that treatment of persistent pulmonary hypertension of the newborn with
inhaled NO (iNO) increases nitrite levels in the blood at least two-fold (21, 84). Although
the resulting nitrite concentrations reached only ~300 nM after iNO administration,
similar increases in circulating nitrite concentrations have been shown to protect mice
against hepatic infarct (85), increase blood flow in the human forearm (86), and decrease
systolic blood pressure in adults (24, 34, 87). Thus, increases in circulating nitrite levels
resulting from iNO treatment may be enough to cause significant systemic effects (21).
Indeed, there are a number of reports demonstrating protective effects of iNO therapy in a
mouse model of myocardial infarction (88), adult human liver transplant patients (89),
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and in children following cardiopulmonary bypass (90). Whether the protective effects of
iNO are due to elevations in circulating nitrite remains to be determined.
Given that nitrite could theoretically improve an infant’s ability to withstand
ischemic stress, it is important to discuss the mounting evidence that normal newborn
infants appear to have numerous mechanisms in place that decrease systemic nitrite levels
during the first few weeks of life. As shown in Figure 23, these mechanisms include low
dietary nitrite and nitrate intake, the lack of bacterial nitrate reduction in the mouth, a
relatively high pH in the stomach, enhanced urinary excretion, and a dramatic fall in
plasma nitrite concentrations at birth.
We have shown that circulating nitrite concentrations decrease markedly after
birth, falling from approximately 0.18 ± 0.02 μM in umbilical cord plasma to 0.08 ± 0.02
μM in plasma collected from term infants on their first day of life. Interestingly, plasma
collected from preterm infants has even lower nitrite concentrations (0.03 ± 0.01 μM).
Plasma nitrite concentrations are significantly lower in infants than those measured in
adults, which averaged 0.17 ± 0.01 μM in our study and typically range from 50 to 300
nM (42). Moreover, plasma nitrite appears to remain lower than adult levels for the first
few weeks of life. These findings are consistent with previous reports that adult plasma
nitrite levels are significantly higher than those of newborn infants (21), but are similar to
those in umbilical cord blood (91). The relevance of the dramatic fall in circulating nitrite
levels immediately after birth is uncertain, but may be an important part of the circulatory
changes that occur at birth.
There are many factors that contribute to plasma nitrite concentrations. In adults,
a majority of plasma nitrite is derived from the oxidation of NO produced by endothelial
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NOS (eNOS) (25). This oxidation depends on enzyme-catalyzed reactions in the plasma
(92), which are significantly attenuated in the newborn (93). In addition, eNOS activity
may be diminished in newborns due to low levels of L-arginine (94) and increased levels
of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of NOS (95-97).
Furthermore, the rapid increase in tissue PO2 that occurs at birth may result in increased
superoxide levels, particularly in preterm infants who are likely to have low antioxidant
defenses (98-101). This superoxide can rapidly scavenge NO to produce peroxynitrite
instead of nitrite. Another potential cause of relatively low plasma nitrite in infants could
be the lack of significant oral bacterial nitrate reduction, as discussed above and
illustrated in Figure 25. We have shown that adults given antibacterial mouth rinse have
significantly reduced plasma nitrite concentrations (14), highlighting the importance of
the oral nitrate reducing bacteria to the amount of circulating nitrite. Thus, with the
confluence of all of these factors, it appears that nitrite bioavailability is diminished in the
newborn by a system of concerted mechanisms, as evidenced by the sharp fall in nitrite
concentrations at birth. The physiological relevance of this decreased nitrite in newborns
remains to be elucidated and should be more fully understood before efforts are made to
study the potentially therapeutic use of nitrite in this patient population.

Summary
Before birth nitrate and nitrite concentrations in fetal blood are similar to those in
maternal blood due to rapid passive exchange of the anions across the placenta. Within
hours of birth, however, the nitrite concentration in the newborn falls sharply in
association with increases in blood pressure, increases in pulmonary blood flow, and
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many other adaptations to increasing oxygen tensions. In the early weeks of life nitrate
and nitrite levels remain low for several reasons. There is limited ingestion of nitrate and
nitrite because their concentrations are low in milk and formula. There is little reduction
of nitrate to the physiologically active nitrite by oral bacteria. There is little generation of
NO in the newborn stomach because the pH is high. Finally, there is enhanced urinary
excretion of nitrite. The net result is that the recirculation of nitrate and nitrite as
bioactive sources of NO is markedly lower in the newborn than in the adult.
In recent decades the many serious concerns that nitrite in the diet would cause
cancer and methemoglobinemia have lessened and been replaced by new findings of
cardiovascular benefits. In the newborn period there arises the prospect of protecting the
GI tract from bacterial invasion by supplementation with nitrite, thereby increasing NO
bioactivity and its protective actions. However, careful investigation must be done
weighing the risks against the benefits before supplementation with nitrite can be
undertaken safely in newborn infants.

Future Directions
One of the most exciting things about research is that in trying to answer one
question, many more questions arise. The continual pursuit of knowledge is what drives
science forward and it is a humbling honor to have been able to contribute my small piece
of the puzzle. Our work has raised important questions regarding nitrite and nitrate
bioactivity in newborn infants and will hopefully lay the groundwork for future studies to
assess the therapeutic potential of nitrite. Indeed, exciting studies are currently underway

119

in our lab evaluating the protective potential of nitrite against hypoxia in the fetus and
newborn.
It is important that future work explore the physiological effects of diminished
nitrite and nitrate ingestion in newborn infants. To address the physiological implications
of chronic low nitrate ingestion, changes could be observed in adults subjected to a lownitrate diet. In addition, future work addressing how human milk fortifiers impact the
nitrate and nitrite levels in breast milk would have important clinical relevance. It would
also be interesting to see whether maternal consumption of a high nitrate diet could raise
the nitrate/nitrite content in breast milk and whether this could be beneficial.
Every day we learn more about the importance of the symbiotic relationship we
have with bacteria. Given the importance of oral nitrate-reducing bacteria, future studies
should identify the age at which oral nitrate reductase activity becomes significant. It
would also be fascinating to explore how bacterial colonization differs in preterm infants
in the NICU versus healthy term infants and how early use of broad-spectrum antibiotics
impact the development of the microbiome. Similarly, studies should be done to
investigate whether seeding an infant’s mouth with the mother’s saliva would be
beneficial for normal colonization of flora. In addition, the effects of chronic use of
antibacterial mouth rinse, in the context of nitrate and nitrite bioactivity, remain untested.
This has important clinical implications as prophylactic chlorhexidine 4 treatment is used
to prevent the oral complications of leukemia (102), HIV (103), and prolonged intubation
(104).

4

Chlorhexidine is the antibacterial mouthwash we used to stop nitrate-reducing activity by oral bacteria in
our studies
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In addition to decreased dietary intake and bacterial activation of nitrate,
decreased gastric NO generation may be another mechanism responsible for the low
plasma nitrite levels in newborns and the particularly low levels in preterm infants.
Future studies should explore this important component of the nitrate-nitrite-NO axis in
newborn infants. As a first step, we collected gastric fluid samples from eleven preterm
infants (<32 weeks gestation), thirteen infants born between 32-37 weeks gestation (late
preterm), and seven term infants (>37 weeks gestation). As expected for newborns, the
average pH of the samples is relatively high (4.4 ± 0.3, preterm; 4.2 ± 0.1, late preterm;
and 3.9 ± 0.3, term) and is higher than the pKa for nitrite reduction to nitrous acid, which
is ~3.2. Consistent with the other aspects of the nitrate-nitrite-NO axis, we see that the
generation of NO from nitrite is greatly diminished due to the high pH of these stomach
contents. Figure 28 shows the rate of NO generation in gastric residual samples at various
pHs, highlighting the dramatic decrease in NO production at higher pH.

Figure 28. Rates of NO production from 50 µM nitrite added to gastric residual samples
(●) and simulated gastric fluid (□) at different pHs.
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However, we were surprised to find that the nitrite concentrations in these gastric
residuals are remarkably high in preterm infants (<32 weeks gestation) (10.8 ± 3.6 µM),
infants born at 32-37 weeks gestation (9.7 ± 2.4 µM), and in term infants (4.5 ± 2.0 µM),
as shown in Figure 29.

Figure 29. Mean nitrite concentrations measured in gastric residual samples collected
from newborn infants during the first three weeks of life. Each data point represents the
mean nitrite concentration in all the samples collected from one infant.

These levels are over a 100-fold higher than the plasma and 100-fold higher than
the levels in breast milk, as shown in Figure 30.
One future direction of our work is to explore this exciting finding. We have
generated a few hypotheses regarding the high nitrite levels in these gastric fluids and
herein present preliminary results that will be useful for determining future work.
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Figure 30. Comparison of the nitrite concentration in the plasma, urine, diet, saliva,
stool, and gastric residuals of infants. Adult values were included when available.

Possible reasons for high gastric nitrite in infants include: nitrate reduction to
nitrite by bacteria, accumulation of breakdown products of breast milk proteins, active
transport across the stomach mucosa, co-transport of nitrite with protons, concentration
of nitrite after loss of volume, and diminished reduction of nitrite to nitrous acid and NO
because of the high gastric pH.
Nitrate reduction by bacteria seems unlikely because there is no nitrite production
after nitrate is added in six of the seven gastric samples measured (Figure 31). Similarly,
breakdown of milk proteins in an acid solution does not cause an increase in the nitrite
concentration (data not shown).
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Figure 31. Nitrate reduction in gastric residual samples. A) After additional nitrate (0.3
mM) was added to seven gastric residuals (represented by individual lines), nitrite
concentrations were measured over 30 minutes (similar to the oral bacteria experiments
described in Chapter 3). B) Mean data represented as % of baseline.

We have promising data from preliminary studies in adult rats testing the
possibility that the high pH in the stomach of newborns is preventing nitrite in the
stomach from being converted to nitrous acid and NO. When 4.0 mL of a high pH buffer
(10mM bicarbonate buffer, pH 8.4), containing 0.02 mg/ml phenol red (a non-absorbable
marker for stomach volume measurements) and 10 µM nitrite, was infused into the rat
stomach, the nitrite concentration remained high over the 30 minutes. Conversely, when a
low pH buffer (1% pepsin in NaCl and HCl, pH 2.0) was infused into the stomach, the
nitrite concentrations fell rapidly during the 30 minutes (Figure 32). In both groups, we
did not see an increase in the nitrite concentration over time despite volume loss,
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indicating that concentration of nitrite because of loss of water is not a likely explanation
for the high nitrite levels in the stomach.

Figure 32. Nitrite concentrations in stomach fluid collected from rats after infusion of a
low or high pH buffer into the stomach.

One intriguing hypothesis is that nitrite is actively pumped into the stomach from
the plasma. To test this, in our preliminary studies we gave rats intravenous (I.V.) nitrite
(0.5 mL of 300 µM) and measured the gastric nitrite levels over 30 minutes. As shown in
Figure 33, when the stomach was filled with saline (pH 5.6) or bicarbonate (pH 8.4), it
appears that the stomach nitrite concentrations rose as the plasma levels fell. However,
when the stomach pH was low (pH 2.0), gastric nitrite levels remained below the level of
detection for the entire 30 minutes. Interestingly, the nitrite concentration in the bile
significantly increases after a gastric or IV bolus of nitrite, suggesting the liver may play
an important role in regulating circulating nitrite levels. These preliminary experiments
provide a starting point for future work that will hopefully shed more light into the
stomach processing of nitrite when the gastric pH is altered, as it is in newborn infants.
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Figure 33. Nitrite concentrations in gastric fluid and plasma after 0.5 mL of 300 µM
nitrite was administered IV.

The exciting and intriguing finding that the gastric contents of newborn infants
contain high levels of nitrite deserves to be explored further. As a first step, we have
ruled out a few hypotheses. It seems unlikely that nitrate reducing bacteria, acid
breakdown of breast milk proteins, or simple concentration of nitrite due to water loss
from the stomach, are responsible for high stomach nitrite. However, very preliminary
work in rats suggest that nitrite may be actively pumped from the plasma into the
stomach where, at a high pH, it can accumulate and lead to higher concentrations than
can be explained by dietary intake. I urge the future generations of students in our lab and
elsewhere to continue to explore this and other potential mechanisms.
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